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ABSTRACT 
This study investigated the response of premature infants to 
parenteral amino acids and related that response to gender, amino acid 
concentration at birth, amino acid status prior to infusion, postnatal 
age, caloric intake, weight, intake of i�dividual amino acids, and ges­
tational age. Plasma samples were collected from 21 premature infants 
(gestational age 31. 2 ± 2. 3 weeks) before the initiation of amino acid 
infusion .and after 24 hours of infusion. Mixed umbilical cord samples 
were available from 1 O of these infants. Eleven ( l 1) infants (gesta­
tional age 30.8_ ± 2.8 weeks) receiving parenteral amino acids_ with no 
enteral supplementation were evaluated at one· week. Plasma amino acid 
concentrations were ·compared to those reported in breast fed term 
infants and in preterm umbilical cord samples. Intakes were compared 
to published recommendations. The amino acid source was Aminqsyn 
· ( Abbott Laboratories, Chicago, 111. ) • 
Neither gender, plasma amino acid concentration at birth or weight 
were influencing factors. Changes in concentration of most amino acids 
appeared to be. more a result of endogenou$ regulati�n than _simple 
intake. Alanine infused at a high concentration showed relatively little 
plasma accumulation while the same concentration of glycine in the infu­
sate lead to excessive plasma concentrations of glycine and possibly 
serine. Plasma concentration of histidine was high in most infants and 
varied directly with gestational age. Plasma phenylalanine levels varied 
inversely with postnatal age and tyrosine concentration varied directly 
vi 
with gestational age. There were indications of cysteine and taurine 
synthes.is in some infants. Methionine intakes exceeded recommendations 
in all infants at one week and were associated with excessive plasma . 
·concentration. Valine concentration varied directly with caloric intake, 
gestational age, and valine intake. Leucine concentration also increased 
with gestational age from 27-33 weeks, but the relationship after that 
time is unclear. 
The amino acid source (Aminosyn, Abbott Laboratories, Chicago, 
.111.) does not appear to have ideal composition for preterm infants. For 
use during the first week of life when intake of both amino acids and 
calories is low, the infusate should contain less glycine and methionine 
and possibly less serine, proline, histidine, and valine. 
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CHAPTER I 
INTRODUCTION 
There is l ittle doubt that the quality of nutrition affects the 
development of the fetus and the infant. There is also l ittle doubt 
that optimal nutrition of the infant born prematurely is v�ry difficult 
· to achieve. The preterm infant is by definition functionally compro-:­
·mised and cannot ingest, digest, assimilate, metabol ize, synthesize, or 
excrete nutrients with the competence of the mature newborn. An 
immature digestive system is a major handicap ( 1). A weak or absent 
sucking reflex is not coordinated with swall owing before approximately 
32 weeks gestation or 1500 grams body weight. An incompetent car­
diac sphincter coupled with a relatively strong pyloric sphincter 
resul ts in frequent regurgitation and danger of aspiration •. The pre­
mature has small stomach capacity and decreased gastric acidity, which 
interferes with protein denaturation. Gastrointestinal immune response 
is low and abdominal musculature is weak. Carbohydrates and proteins 
appear to be sufficiently digested and absorbed, but fat absorption is 
poo_r ( 2). In addition to these basic problems,· complications su�h as 
respiratory distress syndrome with assisted ventilation make oral . feed­
ings impossible. There has been, therefore, a long recognized need to 
provide· intraven�us nutrition for very premature infants while the . 
gastrointestinal tract matures. 
Two reports in 1966 mark the beginning of serious attempts at 
intravenous al imentation in premature infants. Cornblath, Forbes, and 
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Phildes (3) demonstrated that early intravenous feedings of glucose to 
very low birth weight infants led to decreased· mortality. Auld,. Bhanga­
nanda; and Mehta ( 4) subsequently showed that hypoglycemia and 
weight loss were also decreased by similar intervention. It was 
Dud rick and associates (5) , however, whose techniques made possible 
the administration of hypertonic dextrose and protein solutions and 
who demonstrated that slow .continuous infusion of these nutrients 
could lead to normal progression of g·rowth and development in term 
infants unable to feed enterally. Since that time pare.nteral nutrition 
has also been used extensively in the management of premature 
infants. 
Although parenteral nutrition is now routine iri most institutions 
caring for prematures, the ideal composition of the inf�sate has yet to 
be determined. Major concerns include (a) optimal growth for the 
preterm infant and the calories and nitrogen necessary to _achieve that 
growth, (b) renal and hepatic function of the premature, (c) effects 
of deficiency and/or excess of individual amino acids in plasma·, and 
(d) development of both synthetic and catabolic pathways at various 
gestational and postnatal ages. 
Altho�gh .clinical impressions suggest that one cannot view all 
prematures as a homogenous group, there have been· relatively few 
attempts to systematically determine differences in amino acid metabo­
lism in vivo according to degree of prematurity. This study assessed 
th� response of infants of varying gestational ages to p·arenteral amino 
3 
acids and related that response to gender, plasma amino acid concen­
tration at birth and immediately prior to infusion, postnatal age, 
caloric intake, weight, intake of individual amino acids, and gestational 
age. Plasma amino acid concentrations were used to evaluate the 
appropriateness of individual amino acid intake and the composition of 
parenteral fluids for premature infants in the first week of life. 
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CHAPTER I I  
REV IEW OF LITERATURE 
This s�udy was concerned with individual· amino acids, their 
intake and their plasma concentrations, in relation to · a number of 
variables. .Following is a selected review of (a) amino acid metabolism 
in the preterm infant, and (b) recommendations for individual amino. 
acid intake and for composition of parenteral fluids for. the prema_ture. 
Amino Acids in the Premature 
Alanine 
Alanine is a nonessential amino acid involved in several aspects 
of human protein metabolism. In addition to participation in protein 
synthesis, alanine is the major amino acid source of glucose in. either 
. . 
the postabsorptive or fasting state. When needed, nitrogen liberated 
from amino acids in muscle is transported as alanine to the liver 
where, in a reversible reaction catalyzed by alanine aminotransferase, 
the alanine is conyerted to pyruvate for synthesis of glucose (6). 
· The fetus presumably does not synthesize glucose in utero, and it 
is ·unclear if there are significant modifications of alanine metabolism in 
the human infant. In rats alanine aminotransferase, differs from other 
enzymes closely involved in gluconeogenesis (glutamate dehydrogenase 
and aspartate aminotransaminase) in that its activity does not increase 
postnatally until weaning (7). In humans the aspartate aminotransfer­
ase is elevated at birth but alanine aminotransferase is not (8). 
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Despite the absence of g luconeogenesis the fetal net uptake of 
alanine �s greatest of all amino acids, and at term it is the only non­
essential amino acid supp lied_ to the fetus in significant quantitie_s (9) . 
Poh landt (10) found no elevated plasma levels despite high intrayenous 
intakes in infants and suggested a lanine as a suitable source of non­
essential nitrogen during parentera l nutrition. Recommended intakes 
for preterm infants vary from 100-700 mg/kg/day (10-13) . 
Arginine and Ornithine 
. In addition to their function in protein synthesis, arginine and 
ornithine are integral intermediates in the urea ·cycle (14) . Both are 
continua lly synthesized in this cycle as arginine is hydrolyzed by the 
enzyme arginase to produce ornithine and urea. The ornithine· is 
reused in a cyc lical process in which it reacts with carbamyl phosphate 
to f orm citrulline which then reacts with a second nitrogen from aspar­
tate to reform arginine. In addition to being recycled, ornithine can 
also be synthesized directly from glutamate in a reaction catalyzed by 
ornithine aminotransferase. Ornithine aminotransferase attains maxi­
mum activity in human liver before the 20th week of gestation and sti l l  
exceeds adult va lues at birth (15) . The high perinatal activity of 
ornithine aminotransferase is in agreement with Snyderman's finding of 
no adv_erse effects of an arginine deficient diet on infant growth and 
deve lopment ( 16) . 
Despite its endogenous production, the addition of arginine to 
parenteral fluids has been found to be clinically advantageous. Gullino 
et a l. (17) observed that arginine decreased the accumulation of 
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ammonia resulting from the deamination of other amino acids. This 
finding has been replicated by others ( 18, 19) and arginine .is now 
routinely used to protect against the toxic effects of ammonia by 
enhancing the urea cycle. 
A second important action of arginine is its stimulation of endo­
genous insulin secretion (20) which tends to be slow and weak in the 
premature infant ( 21) . The release of adequate insulin is necessary 
for proper assimilation of the concomitantly administered glu�ose and 
the prevention of hyperglycemia. Arginine infusion has also been 
shown to induce the release of an immunodetectable growth hormone 
(22) . which, in addition to other actions, is thought to impair insulin 
inactivation and thus prolong insulin half-life (23) . 
Although considered a nonessential amino acid, significant amounts 
of arginine are now almost universally added to total parenteral fluids. 
As a basic amino acid it serves a useful function in increasing the p H  
of the parenteral solution, .thereby decreasing the chance of metabolic 
acidosis. Arginine is exceedingly well tolerated at doses as high as 
1200 mg/ di ( 11) , but the fetus is thought · to extract less than 87 
mg/kg/day at term from umbilical plasma (10) . Dosage recommenda­
tions for arginine vary from 110-250 mg/kg/day (10-13) . Administra­
tion of ornithine is not considered necessary when adequate arginine is 
provided. 
Glycine and Serine 
Glycine and serine are nonessential amino acids which can be 
interconverted through the glycine cleavage system (8) . Serine can 
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also be synthesized from glucose ( 14) . The enzyme involved in the 
equilibration of serine and glycine, serine hydroxymethyl transferase, 
has been found to be as active in human fetal and newborn liver and 
kidn·ey as in adult tissues ( 25) . 
Glycine is utilized in the synthesis of proteins, heme, purines, 
glycocholate, glutathioine, hippuric acid, and creatine. Serine, in 
addition· to its interconversion with glycine, p�rticipates in · the syn­
thesis of cephalins, ethanolamine, choline, cysteine and glucose. Both 
of these amino acids are metabolically active and have rapid turnover 
rates ( 14) . 
Because it is comparatively cheap, glycine has been used as a 
means of increasing the nitrogen content of parenteral amino acid. solu­
tions. This high glycine intake has not always been innocuous, how­
ever, as it has been associated on several occasions with hyperammo­
nemia and hyperglycinemia (11) . The premature's need for glycine is 
unclear as Pohlandt (10) found very little. daily fetal extraction of 
glycine from umbilical plasma, whereas Jackson (26) has estimated a 
fetal requirement of 220 mg/kg/day for anabolic .purposes only. 
Recommendations for intravenous intake of glycine range from 100-400 
mg/kg/day and serine from 98-200 mg/kg/day (11-13) . Pohlandt (10) , 
however, found a much lower combined dose of only 50 mg/kg/day 
necessary to prevent undesirably high plasma levels. 
Histidine 
. Histidine is considered an essential amino acid in children and 
infants but not in adults. Assumption of its endogenous production is 
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based on Rose's observation that 3 adult males remained in nitrogen 
balance when fed a synthetic histidine-free diet for 8 days .. (27) ; 
Snyderman et al. (28) ., however, found that infants fed· a _diet lacking 
histidine developed a skin rash and had a reduced growth rate· and 
lower nitrogen retention when compared to controls receivi.ng histidine. 
The synthetic pathway utilized in humans and the effects of low die­
tary histidine over longer periods of time have not yet been fully 
determined. 
Histidine . is utilized in protein synthesis and formation of hista­
mine (14) . The term fetus extracts approximately 120 mg/kg/day from 
. umbilical plasma ( 11) , and recommended parenteral intakes vary from 
48-120 mg/kg/day (11-13) . 
Leucine, I soleucine, and Valine 
The essentiar amino acids leucine, isoleucine, and valine are called 
branched chain amino acids because each contains a methyl group 
which is not part of the longest carbon-to-carbon chain (14) . As a 
group they are �nique in that the major site of their metabolism is not 
liver as it is for other essential amino acids. The branched chain 
amino acids instead pass through portal circulation a·nd liver virtually 
unchanged (29) and travel via plasma to target organs where they are 
incorporated into proteins, metabolized into nonessential amino acids, 
or catabolized in muscle, kidney and gut wall ( 11) . Catabolism begins 
with reversible transamination into keto acids ( 8) . The transaminase 
for branched chain amino acids is most active in muscle (30) which, by 
virtue of its size and enzymatic activity, becomes important in nitrogen 
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metabolism. The prematu·re infant's muscle mass is in no way. compar­
able to that of an adult (25% vs. 45% of body weight),  suggesting 
potential alterations in the metabolism of branched chain amino acids in 
the premature. 
A second somewhat unique characteristic of branched chain ·amino 
acids is their antagonistic relationship. Harper and associates (31) 
were first to observe that excess supply of any one of these amino 
acids inc�eased the requirement for the other two in the rat. Swend­
seid ( 32) documented this effect in ·humans who developed depressed 
plasma levels of isoleucine and valine following excessive leucine 
intakes. The exact mechanism for this antagonism is �nknown, but its 
existence should be considered in formulating amino acid soluti.ons for 
parenteral use. 
Leucine is somewhat similar to arginine in its ability to stimulate 
secretion of insulin (20) . Stimulation of insulin is thought to be an 
advantage in the premature as it is the primary growth promoting 
hormone in the fetus, newborn, and very young infant (33) . 
Leucine, isoleucine, and valine are frequently recommended as 
sources of nonspecific nitrogen in parenteral fluids. A wide range of 
intakes of branched chain amino. acids have been given without excess­
ive elevation in peripheral blood ( 11) . This may be due to diverse 
metabolic pathways which could be protective in the event of excessive 
branch chain amino acid intake. 
At term, fetal extraction is approximately 59 mg isoleucine, 
122 mg leucine and 187 valine per kg/day from the umbilical plasma 
( 1 O) . Recommended intravenous intakes for premature infants vary 
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from 60-200 mg/kg/day of isoleucine, 125-400 mg/kg/day· of leucine, 
and 100-700 mg/kg/ day of valine (10-13) . 
· Lysine 
Lysine has been recognized as an essential amino acid for m�ny 
years, yet knowledge of its metabo lism is fragmentary. In addition to 
participating in protein synthesis, lysine is a source of butyrobetaine, 
a precursor of carnitine, the intracellular transport agent for fatty 
acids, but other functions remain obscure (14) . As exemplified by the 
greater than two-fold variance in recommendations for oral  intake, 
estab lishment of requirements is difficult ( 11) . Lysine is we ll con­
served and efficier:-itly recycled in times of limited intake, perhaps 
because of the marked tendency of muscle to store free lysine ( 6) . 
The sma ll muscle mass of infants is possibly a disadvantage in this 
regard as they. may lack a sufficient reservoir for dealing with excess 
p lasma lysine. As the most potent inhibitor of arginase, the enzyme 
responsible for c leaving urea from arginine, lysine could interfere with 
ammonia elimination if its concentration sign.ificantly exceeded physio­
logical levels (3 4) . Hyperlysinemia has a lso been associated with 
menta l retardation e�en when plasma lysine levels are only · moderately 
e levated (34) . From a teleo logical point ·of view, a possible argument 
against attempts to maintain low plasma concentrations is the observa­
tion that the fetus has a very high intrauterine lysine concentration 
and a dai ly lysine retention of approximately 336 · mg/ kg/ day ( 1 O) . 
Recommendations for parenteral intake vary from 120-334 mg/ kg/ day 
( 1 0- 1 3 ) . 
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Methionine and Cysteine 
Methionine is an essential sulfur containing amino acid and · is · the 
substrate for the synthesis of taurine and cysteine . In addition, 
methionin� participates in protein synthesis and is a source of methyl 
groups for nu_cleic acid modification, . methylation of amino acid residues 
and the synthesis of a large number of biological · compounds including 
creatine, epinepherine, and. phosphatidyl choline . Cysteine, likewise , 
is involved in the synthesis of such important compounds as glutathio­
ine , iron sulfide complexes, keratin and various enzymes ( 14 ) .  
I t  is well accepted that the transsulfuration pathway is the means 
by which older children· and adults convert the sulfur of ingested 
methionine to . cysteine (35) . There is considerably less ·certainty 
about the formation of cysteine in the newborn however . In 1972 it 
was reported that the activity of cystathionase, th� last enzyme in the 
pathway of transsulfuration of methionine to cysteine, is · virtually 
absent in extracts of human fetal liver and brain during the second 
. . 
trimester (36 ) . Indications from animal studies are that cystathionase 
activity is low in l iver throughout gestation and low in brain through­
out pre- and postnatal development (37) . Further, the human placenta 
has been found to have no transsulfuration enzyme activity, suggest­
ing that the fetus is entirely dependent on the mother for cysteine 
( 36-38 ) . 
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Feeding studies appeared to support the view of cysteine as an 
essential amino acid when Snyderman (39) reported at lea�t or:1e pre­
term infant who still had a need, based on nitrogen balance and 
growth studies, for dietary cysteine at 5 months of age . This has 
been, however, the only published case of cysteine deficiency, and .the 
methodological and clinical details of that study have never been 
reported. Cystathionase activity in other studies appeared to be a 
postnatal phenomenon with adequate activity in both te�m and preterm 
infants appearing about the second postnatal week ( 40) . Full activity 
was reached more slowly in premature than term infants ( 25) . Signifi­
cant cystathionase has recently been found in the human fetal kidney. 
All enteral formulas contain considerable amounts of cysteine, but 
only one commercially available intravenous amino acid solution (Vamin, 
Pharmacia ., Montreal, Quebec) contains cysteine in significant amour:,ts 
· ( 41) . The absence of cysteine is primarily due to poor solubility ( 42). 
Despite the fact that acceptable nitrogen retention and growth . have . 
been reported in infants given cysteine-free intravenous solutions 
( 43 ) , the suspicion rema ins that cyste ine mig ht be a lim.it i ng amino acid 
for protein synthesis and growth in the · low birth weight infant in the 
early days of extrauterine life. 
In  1981 Z lotki n, Bryan, and Anderson ( 41) repo_rted resu Its of 
the first clinical study done to determine the essentiality of cysteine 
for the intravenously fed infant . They found no difference in nitro·­
gen ret�ntion, weight change, or growth in length or head circumfer­
ence between control infants and those supplemented with 77 mg of 
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cysteine per kg/ 24 hours. The supplemented group did have a 60% 
increase in plasma cysteine and a 300% · increase in urinary cysteine 
excretion. Possible reasons for lack of · difference·s between groups 
include a short balance period (3 days following a 3 day adaptation 
period) , . errors inherent in nitrogen balance studies per se ( 44) , 
and/or the nonessentiality of cysteine. A note of caution was intro­
duced when sulfur balances indicated a significant increase in plasma 
sulfate ( 45) .  The authors suggested that the addition of cysteine to 
an intravenous solution already high in sulfate because of the antioxi­
dant perservative potassium bisulfite ( su.ch as contained in Aminosyn) , 
could result in sultate accumulation with · unknown metabolic effects. 
Increased sulfate has been related to hypercalciuria and may be an 
etiological factor in the bone disease associated with parenteral nutri­
tion in preterm in fan ts ( 46 ) .  
Malloy et al. ( 47) compared cysteine supplemented infants with 
controls receiving total parenteral nutrition for 6 days and essentially 
replicated Zlotkin's findings. The addition of cysteine was associated 
with increases in plasma and urine cysteine but no differences in 
weight gain or nitrogen retention. There was again greater retention 
of sulfur possibly indicating that cysteine was preferentially reta1ned. 
The question of whether cysteine is an essential �mino acid for all 
infants, for those receiving intravenous nutrition, or for infants of 
certain gestational and/or postnatal ages has yet to be answered. On 
the other hand, methionine is unquestionably an essential ami.no acid 
for all ages . There is concern about the proper . intake � however, as 
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animal experiments indicate that high doses are far from innocuous. 
Sauberlich ( 48) and Peng ( 49) , working independently, found. that 
based on growth depression, methionine was the most toxic of the 
essential amino acids . If the premature infant does have significant 
alterations in the transsulfuration pathway and less synthesis of sulfur 
containing amino. acids, careful attention must be given to methionine 
intake if toxicity is to be avoided. 
The fetus at term extracts approximately 15 mg methionine and 
19 mg cysteine per kg/day from the umbilical plasma (10) . Recom­
mended intravenous intakes for methionine vary from 15-80 mg/kg/day 
and for cysteine from 0-85 mg/kg/day (10-13).  
Phenylalanine and Tyrosine 
Phenylalanine and tyrosine are known as aromatic amino acids 
because of the �resence of a benzene ring in their carbon structures 
(14) . Both are involved in protein synthesis . and tyrosine is, in addi­
tion, a substrate for the synthesis of epinepherine, norepinephe rine, 
thyroxin, and melanin (8) . In the human adult, tyrosine is a. non­
essential amino acid derived from the irreversible hydroxylation of 
phenylalanine by phenylalanine hydroxylase (14) . Phenylalanine must . 
be supplied in the diet for individuals of all ages, but the need for an · 
exogenous source of tyrosine in the premature has been a source of 
debate. Based on nitrogen balance studies in infants fed a defined 
mixture of amino acids, Snyderman (39) suggested that tyrosine was 
essential in the premature infant. Raihi (SO) , however, was able to 
demonstrate some activity of phenylalanine hydroxylase as early as 
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the 8th week of gestation and acti v ity simi la.r to . that of the adu lt by 
the 1 3th week . It appears , therefore , that the enzymatic  me�hanism 
for conversion of phenylalanine to tyrosine is present in the viab le 
premature , but it is possib le that the activity of th is  enzyme comp lex 
is inadequate for the rapid growth of the premature , and there may be 
a requirement for exogeno·us tyrosine . A second consequence of de­
layed maturation of the phenylalanine hydroxylase system is transient 
phenyla lanemia ( 1 2  f. 
Elevated p lasma levels of tyrosine result ing in a disorder known 
as transient neonatal  tyrosinemia  are also a concern . Ev i dence regard­
ing its significance is conflicting , but at least two investigators . have 
associated e levated p lasma tyrosine with subsequen·t learning · disab i l i­
t ies ( 5 1 , 5 2 ) . Transient neonatal tyrosinemia is thought to occur as a 
consequence of the re lative delay in the maturation of p-hydoxyphenyl­
pyruvic  acid ox idase , an enzyme involved in tyrosine catabo lism ( S O ) . 
S ignificant elevations of tyrosine occur more frequent ly in prematur� · 
than fu l l -term neonates and in those infants recei ving a high protein 
· intake ( 52 ) . 
While the duration of tyrosinemia and phenyla lanemia are undoubt­
ed ly important in the development of adverse outcomes , the nutrit ional 
goal is to satisfy requirements for _ growth and development but spare 
the vu lnerab le  brain any potenti al insult resu lt ing from hyperamino­
acidemias . Proper dosage of these amino acids are consequent ly 9f 
great concern . The term fetus extracts approx imately 5.4 mg of tyro­
sine and 59  mg of phenylalanine per kg/day from umbi l ical p lasma 
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(10 ) . Recommendations for tyrosine intake vary from 0-120 mg / kg/day 
and for phenylalanine from 59-230 mg /kg/day_. The amino . acids 
. . 
should, however, be considered together when deter�fning dosages as 
the administrati on of tyrosine will decrease the requirement for phenyl­
. alanine ( 1 0-13 ) . 
Prol ine 
Prol i ne is a gluconeogenic amino · ac id found . in many· body pro­
teins . Its maj or synthesis is from glutamic acid via glutamic semi­
aldehyde- and its primary catabolic pathway takes the reverse pathway 
but through a di fferent enz yme system ( 53 ) . Proline · may also be 
hydroxylated to form hydroxyproline, a major constituent of collagen, 
or may be converted to ornith ine ( 54 ) .  Although prol i ne is � non­
essential amino acid, question has been raised about the adequacy of 
its endogenous production . Watts, Bradley and Mann ( 55 ) suggested · 
that the rate of synthesis or proline was less than that of other non­
essential amino acids .  Juergens and Doli f (56 )  found improved nitro­
gen balance following proline enrichment of parenteral solutions con­
taining essential ami no acids as proposed by Rose for adults .  · Heine 
( 57 ) ,  however, found no effect of proline supplementation on nitrogen 
balance in 6 infants receiving prol i ne-free parenteral solutions con­
taining essent ial amino a_c ids a� proposed by Rose with glycine added 
as a nonessential nitrogen source . High intakes of proline and /or 
marked imbalances of amino acids have, on the other hand, been 
associated with hyperprol inemia . in infants ( 1 O, 56 ) .  In adults 
17 
· undergoing parenteral a l imentation, pro l i ne was found to be ·second 
only to val i ne in its rise in blood concentrati on per mi l l imole · infused 
per hour, suggesting that its degradation or use in protein synthesis 
was l im ited (58) . The fetus extracts approximately 127 mg/ kg/ day 
from umbi l ical p lasma ( 1 O) . Recommended i ntravenous. intakes· fo _r 
infants range from 50-135 mg/ kg/day (10-13.) . 
Taurine 
Taurine is an abundant and ubiquitous su lfonic amino ac id (59) • 
. A long with inorganic sulfate, it is the major end product . of met� ionine 
metabolism in mamma ls. Considerable biochemical evidence exists, 
however, that taurine is n�t mere ly an end product of sulfur metabo­
l ism but rather a functiona l ly important metabolite. Wh i le · its actual 
ro les have not been ful ly characterized, multiple functions are sug­
gested. Taurine may_ act as a neurotransmitter or neuromodulator in 
the b_ra in where it has been impl icated in epi lepsies in both human and 
animal models (60) . I t  is thought to be a regulator of membrane exc.it­
abi l i ty in card iac and skeleta l muscles. It may pl ay a role in the 
maintenance of the structura l integrity of the retina, especia l ly the 
photoreceptor ce l ls, and may be involved in endocrine and reproduc­
t ive function (61) .  
At the present t ime the only proven biochemical role  for taurine 
in man is its conjugation with b i le  acids to form bi l e  salts. Unl ike . 
many other species, the human can conjugate bi le ac ids with either 
glycine to form glycocholate or taurine to form taurocholate (62) .  The 
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taurine conjugated bile acids are more efficient as they are less ,likely 
· to be deconjugated and degraded by gut flora. They, therefor�, have 
s lower fornover rates and greater conservation in the enterohep.atic 
circulation (63) . They also mainta in critical mice llar concentration 
further down the gut (64) . It has also been shown that bile acids, 
· especially taurocholate, are important in the control of hepatic choles-
. ' 
tero l synthesis and, therefore, of total body cho lesterol pool size (65, 
66) . 
Taurine is not considered essential for either children or adult_s, 
but several lines of evidence suggest that the premature infc�nt may 
have a need for an exogenous source of taurine. The enzyme involved 
in what is presumed to be the major synthetic pathway, cysteine sul­
finic acid decarboxylase, has very low activity in the fetal I iver ( 64) .  
The finding of a very high concentration of .taurine in ttie brain dur­
ing development at a time of limited capacity for synthesis implies the . 
need for exogenous taurine ( 67) . This high concentration in fetal and 
newborn brain decreases slowly postnatally (68) and has lead to the 
. suggestion that taurine may have a role in the development as we ll as 
function of the brain (64). 
Taurine is present in higher concentration in human milk (25-35 
microm�les /dl) than in infant formula (1-3 micromoles/dl) �r cow's milk 
( 1 micromole /dl) from which most such formulas are derived. Commer­
cially availab le soy formulas contain no taurine (69) . Infants fed 
human milk remain primarily taurine conjugators of bile acids whereas 
those fed taurine deficient formula become predominately glycine conju­
gators ( 70) . This abi lity to conjugate with either glydne or taurine 
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may be an important safety mechanism to prevent deplet ion of li mited 
supplies. Both preterm and term infants fed artificial formulas have 
been shown to have significantly lower concentrations of taurine in 
their plasma and urine than did infants fed human mil k ,  suggesting a 
dietary requirement in the rapidly growing neonate ( 40 , 71 ) .  Jarven­
paa et al. (72) , however , found that taurine supplementati on of whey 
predominant formulas had no effect on growth of premature infants 
either in the immediate postnatal period or for up to 4 months post'.... 
natally. 
Studies of taurine metabolism during total parenteral nutrition are 
very li mited. Beagle pups , whose sulfur metabolism is similar but not 
identi cal to that of humans , had a decrease in ta urine conjugated bile 
acids after being tre.ated with taurine-free but methionine-sufficient 
parenteral fluids for 1 4  days ( 73).  The significance of  this  is uncer­
tain. While not a factor during parenteral nl:1trition , an adequate bile 
salt pool may be important in the successful initiation or reinstitution 
of enteral feedings. 
Rigo and Sente rre ( 7 4 )  mon itored 1 4  low birth weight infants 
perfused with a solution described as having no taurine and little 
cysteine. They found · consistently low levels of plasma taurine in both 
the under 1 500 g and under 2000 9. babies. The investigators felt · 
these results indicated that preterm infants have a li mited capacity for 
taurine synthesis from cysteine and methionine precursors and may be 
dependent u·pon an external taurine supply for adequate growth . and 
development. Commercial amino acid solutions currently contain no 
taurine. 
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Threonine 
Threonine is an essential amino acid for both adults and infants . 
I n  addition to participating in protein synthesis·, it is a precursor for 
glycine, alanine, and asparagine, but these can be readily synthesized 
from other amino acids ( 11) . Hydroxyl groups of threonine residues 
are also a frequent site for carbohydrate linkage in the formation of 
glycoproteins ( 14 ) .  
The fetal plasma .concentration of threonine is high, but the sig­
nificance of this elevation is unknown . The intravenous administration 
of high doses of threonine has been associated with hyperammonemia 
and · hyperthreonemia. Ghadimi found intakes in infants of more than 
100 mg/kg /day frequently resulted in marked elevations of plasma 
threonine, whereas levels remained within acceptable limits when 
intakes were limited to 60 mg/kg/day (11) . Term fetal extraction from 
cord blood is approximately 131 mg/ kg/ day ( 1 O ) ,  and recommended 
parenteral intakes for infants vary from 60-150 mg/kg/day ( 10-13 ) . 
Tryptophan 
Tryptophan is an essential amino acid required for the synthesis. 
of body protein and the synthesis of at least 3 physiologically active 
substances : serotonin, nicotinic acid, and melatonin ( 8 ) . The . pri­
mary catabolic pathway for tryptophan involves the conversion of 
tryptophan to formylkynurenine by tryptophan pyrrolase ( 14 ) . This 
enzyme is apparently present in most term infants but is · reported to 
be absent in the premature ( 7 ) . Tryptophan is usually the least 
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abundant amino acid in the diet and is generally the amino acid sup­
plied in the smallest amounts in parenteral fluids . The fetus e?(tracts 
approximately 124 mg/kg/day at · term from umbilical plasma · ( 10) . 
Recommendations for intravenous intakes are fairly uniform around ·30 
mg/kg/day except for that of Pohlandt who found 80-120 mg/kg/day 
necessary to maintain acceptable plasma tryptophan levels ( 10-13 ) . 
Recommended Intakes of Parenteral Amino Acids 
for the Premature 
Table 1 presents the recommendations of several investigators for 
parenteral intake of amino acids in the preterm infant . These recom­
mendations were determined in a variety of ways . Snydermari ( 13 ) 
based · her recommendations on the oral amino acid requirements of full 
term infants . She multiplied requirements fo� essential amino acids by 
a factor of 1 .  3 to allow for individual variation . This factor was 
chosen rather than the traditional 2 to compensate for the 10-15% of 
ingested nitrogen normally lost in the stool of enterally fed infants and 
because of "concern for harmful excess . "  Nonessential amino acids 
were recommended in the proportions found in human milk with the 
exceptions of gl_utamic acid and aspartic acid which were recommended 
in minimal amounts . Snyderman recommended that the nitrogen that 
would have been supplied in glutamic and aspartic acids be supplied 
instead in glycine and alanine. 
TA B LE 1 
Recommended pa rentera l ami no ac id i n ta kes 1 
Gha d im i 2 Steg i n k3 B u rg e r  4 Poh landt 5 Snyde �man 6 
Aspa rtic Acid  1 2 . 5  7 1 7 1 3 5 0 40 
G lutamic  Ac id  1 2 . 5  72 8 49 0 0 4 0 
Th reon ine  6 0 1 43 1 5 0 60- 1 3ij 1 2 0 
Ser i ne 1 0 0 98 8 0  50 1 3 8 
Pro l i ne 5 0 1 3 2 1 3 5 1 2 0 9 1 6 0 G lyc ine 1 0 0  2 0 3 2 5 5  5 0 3 3 0  
· A la n i ne 1 0 0 2 8 2  290 3 2 0-7 0 0  3 7 0  
Va l i ne 2 0 0 1 8 8 8 0  1 8 0 1 40 
Cyste ine  8 5 8 4 5 0 . 40 6 0 
Meth ion i ne 1 5 5 4  40 2 2-45 6 0 N N 
l soleuci ne 2 0 0  1 2 7 70 60 - 1 0 0 1 5 0 
Leuc ine  40 0  2 1 6 1 2 5 1 3 0-2 1 0  2 0 0  
Ty ros i ne 1 2 . 5  79 5 0 2 0  1 2 0 
Pheny la lan i ne 1 0 0 1 04 95  5 9- 76 1 2 0  
Tryptophan 3 0  43 3 0  8 0- 1 2 0 3 0  
Lys ine 1 2 0 3 3 4 1 6 0 1 75-3 3 0  1 40 
H istid i ne 50 74 1 1 0  5 0- 1 2 0 48 
Arg i n i ne 2 5 0 1 87 1 1 0 2 1 0  1 0 2 
Tota l 1 89 7 . 5  3 069 2 5 0 0 1 0  1 5 76-2 45 2 36 8 
1 A l l  va l ues a re mg / kg /day . 
TAB LE 1 { conti n ued ) 
2G ha d i mi , H .  { 1 975 ) Newly devi sed . ami no acid so l u tions  for i nt ravenous adm i n i stration . 
I n :  Tota l Pa rente ra l  Nutrit ion : Prem i ses a nd Prom i ses { G had im i , H . , ed . ) ,  pp . 93-442 , John 
W i ley & Son s , New York � 
3steg in k ,  L .  D .  { 1 975 ) Deve lopment of a c rysta l l i ne am ino ac id  m ixtu re for pa ren te ra l a l i ­
mentation of  young infants . I n :  I n travenou s N utr i tion i n  the H ig h  R i s k  I n fa nt { Wi nte rs ,  R .  W .  
& Hasse lmeyer , E .  G . , eds . ) ,  pp . 4 1 1 -42 0 ,  John Wi l ey & Son s ,  New Yo rk . 
4B u rger , _ U .  & Wol f, H .  { 1 976 ) I nvestiga tions on the ut i l i zat ion of  pa ren te ra l ly adm i n i stered 
am ino  ac ids  by prematu re and hypotrop ic  neonates . Eu rop . J .  Ped iat r .  1 22 ,  1 69 - 1 75 . 
5 Poh landt , F .  { 1 979 ) Stud ies on the requ i rement of  amino  ac ids  i n  newborn infants receiv- . 
i ng pa rente ra l nutr it ion . I n :  Nutr it ion a nd Metabol i sm of the Fetus and I n fa nt { Vi sse r ,  
H .  K .  A . , ed . ) ,  pp . 341 -364 , Ma rtinus  N ijhoff, the H ag ue . 
6 sn yderman , S .  E .  ( 1 97 5 ) Amino ac i d  requ i rements . I n :  I ntravenou s N utr i ti on i n  the H ig h  
R i sk I n fa n t  ( W inters , R .  W .  & Hasselmeyer ,  E . G . , eds . ) ,  pp . 2 0 5 -2 1 4 ,  John Wi ley & Son s , 
New Yo rk .  
7 Pl u s  7 1  mg / kg / day aspa rag i n e .  
8 Pl us  587  mg / kg / day g l utamine . 
?combi ned �ose of g lyc i ne· and se r ine . 
1 0 1 nc l udes 45 mg / kg / day orn ith ine . 
"' 
w 
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Steg i n k  ( 1 2 )  ba sed h i s  recommenda tions  o n  th ree sou rces : 
( a )  Snyderma n ' s  essen ti a l  am i no aci d req u i rements for ora l l y  fed term 
i n fants , . ( b )  the · am ino ac id concentration of cord b lood , and ( c )  p l as-
ma am ino aci d  concentrations of infa nts i n fu sed w ith d i fferent prote i n  
hyd ro lysate so l ution s . Snyde rman ' s  va lues for a I I  a m i no ·ac ids  we re 
ta ken as the a bso lute m i n imum even w hen they we re h igher tha n the 
. va l ues obta i ned by other cr i ter ia . T h i s  was the ca se w i th meth ion ine , 
i so leuc ine , · leuc i ne , pheny la l an ine , h i stid i ne , and lys ine . For otr,er 
amino acids the leve l s  ca lcu lated from cord b lood were se l ected w i th 
t he exceptions of g lyci ne , w h fch was i ncreased to prov i de noness�n t ia l  
n itrogen , a n d  th reon ine , wh ich  was averaged becau se of i ts d i sp ropor­
t iona l ly h i g h  cord concentration . 
G had im i  ( 1 1 )  eva l uated the to lerance to increa s i ng doses of amino 
ac id so l u tions to arr ive at h is  recommendation s . Subjects were 8 
i nfa nts less than 7 months of _age and 5 2  neonates , i nc lud i ng _ 35  prema ­
tu res of undescr i bed gesta tiona l age .  Ami no ac id  sol u tions we re based 
on " metabo l ic pathways of eac h  a mi no aci d w ith  emphas i s on economy of 
t he substanc� , the role of d i fferent ti ssues i n  metabol i sm ,  s i de effects , . 
n itrogen req u i rement ,  en zymic immatu r i ti es , and m i n i ma l  and sa fe ora l  
requ i rements of essen tia l  am i no ac ids . "  P lasma aminog rams determ ined 
after i n c reas i ng amounts of test so l u tion s  were often dec i s ive i n  
se lect i ng the u pper l im it of recommended dosage ra nges . 
Poh la ndt ( 1 0 ) approached the ta s k  i n  two ways . He fi rst of .a l l  
assumed that the i ntraute r i ne su pp ly  of nutr ients to the fetus i s  the 
idea l  mode l  for pa rentera l  i n fu sate com pos i tion and used feta l retention 
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of amino acids as one basis for h is recommendat ions . Fetal retention 
was based on d ifferences in umbil ical cord . ve in and artery amino acid 
concentration of 46 infants w ith gestational . range of 35-42 weeks, 
med ian age 40 weeks.  Esti mates of fetal retention were calculated by 
multi plying the med ian d ifference between venous arid arterial concen­
trat ion by the rate of blood flow in cord vessels .and assum�ng a 
hematocrit of 49% . The second basis for h is recommendations was the 
response of 1 1 8 "mostly premature" infants to 7 different am ino acid  
solutions. As w ith other investigators results from the two a·pproaches 
were not al ways in agreement .  In such cases, Pohlandt Lis�ally fav­
ored the data representing fetal retention .  
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C H A PT E R  I l l  
EX PE R I MEN T A L  PROC E D U R E  
Low b i rth wei g ht infa nts adm itted to the neonata l i n ten s ive ca re 
u n i t  of T he U n i versity of Ten nessee Memoria l Resea rch Cen ter a nd 
. . 
Hospita l  in  Knoxv i l l e , Tennessee , from Janua ry to J u ne 1 98 2  were · 
cand idates for the study . Cr ite rion for inc l u s ion was that the i n fant  
wou l d  be  g i ven an intravenou s g lucose-amino acid so lution for at lea st 
24 hou rs w ith no entera l feed ing . T he deci s ion regard i ng method of 
feed i ng was made by the neonatolog i st independent of the research . 
T he study protocol was rev iewed and a pproved by the the Resea rch on 
H u man Subjects Commi ttee of  .The U n ivers ity of  Tennessee . T he pro-: 
posed study was fu l ly exp la ined to at least one of each ch i l d ' s  
pa rents , a n d  w r itten con sent was obta i ned before inc lu s ion · i n  the 
study . Consent was n<:>t soug ht when the mother ' s  phys ica l cond it ion , 
the i n fa nt ' s prog nos i s  or immed iate treatment. needs ,  the presence of 
obv ious congen ita l a noma l ies , the death of a twi n ,  or any other factor 
made a d iscuss ion of resea rch pa rtici pation i nappropriate . . For th i s  
reason , an� becau se of the i r  very sma I I  b lood vol u me , the sma I I  est a nd 
most immatu re i n fants were not inc l uded i n  the study . Gestat iona l  age 
· was ca lcu lated from da te of mother 's  last men strua � per iod and Dubo­
w itz scori ng ( 75 ) . 
I n fa nts · received i n fu s ions of g lucose so l u tions from the t ime of 
admi ss ion unti l the a m i no ac id-g l ucose sol ution ( tota l pa ren te ra l  nutr i­
t ion ) was i n i ti ated , usua l ly on the second or th i rd day of _ l i fe .  
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N itrogen was su ppl ied as  a crysta l l i ne L-amino ac id  mi xtu re ( Am i nosyn , 
Abbott Laborator ies , North Ch icag o ,  1 1 1 . ) .  T he infusate was .formu­
lated to prov ide adequate minera l s ,  trace meta l s , and v i tam i n s , i n · 
add it ion to 1 5  am i no acids . Changes i n  e lectro lytes we re made as  
i nd icated by the infa nt' s se rum va lues . 
T he i ntravenous sol ution s ,  a septica l l y prepa red by the hospita l 
pha rmac ist under _ l am inar  flow , were de l ivered into umb i l i ca l  artery 
cathete rs or peri phe ra l  l i nes th roug h O .  22 m ic ron i n l i ne fi l ters . Rate 
of de l ivery was contro l l ed by cont i nuous flow i n fu s ion pumps , and  
i nta ke was ca lcu lated and recorded hou r l y .  Aseptic precaut ions w_e re 
meticu lous ly  observed i n  ca r ing for the catheter , da i ly changes of flu id  
and  tl:,lb ing , etc . A l l  i nfus ions we re beguri  and b lood samp les co l l ected 
between 4 :  00 and 6 :  00 p. m. to negate the effects of d i u rna l va r iation 
( 76 ) . 
Du ri ng the study per iod a l l  i n fa nts were ca red for u n der rad iant  
overhead heaters or in servocontro l l ed i ncubators . They rece ived no 
i nsu l i n du ri ng the study . 
I n fants were weighed da i ly between 7 : 00 and 8 : 00 a . m .  Weights  
at  i n it iat ion of am i no acid infu s ion ( 4 : 00-6 : 00 p . m . ) and 2 4  hou rs later 
were ca lcu lated by interpo lat ion . The ca lor ic  and  ind iv idua l  amino ac id  
in ta kes we re ca lcu lated from the composit ion and amou nt of infusate 
g iven each infa nt in the 24 hours before samp le  co l l ection s .  
Samp les of O .  8 m l  o f  w hole b lood we re co l lected i n  hepa ri n i zed 
. syr inges from umb i l ica l catheters just pr ior  to i n i ti ation of ami no ac id  
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infusion and 24 hours later . Samples f rom heel sticks wer� also collec­
ted at one · week of age f rom in fants on total parente ral nutrition with 
no entera l  intake. When possible cord blood samples we re collected · 
immediately after delfvery and before pla.cental separation from infants 
born at The University of Tennessee Memorial Hospital and Research 
. . 
Center but were not available from infants transferred to this regional 
facility. 
Whole blood samples were centrifuged and the plasma decanted 
and f rozen at -20 C. After thawing at room temperature and dep ro-:­
teinization with 1 % picric acid, plasma amino · acids were separated by 
one column ion exchange chromatography . using the J CL-6AH Amino 
Acid Analyz'er ( JEOL Ltd. , Tokyo, Japan ) ,  modified as previously 
described by Lin ( 77 ) .  This method allowed quantitative estimation of 
histidine, ornithine, lysine, arginin·e, taurine, aspartic acid, th reo­
nine, serine, glutamic acid, p roline, glycine, alanine, cysteine, .valine , 
methionine, isoleucine, leucine, tyrosine, and phenylalanine concent r­
ations in the samples col lected at delivery , just p rior to initiation of 
amino acid infusion, and after 24 hours of infusion. Samples from one 
week old infants were analyzed by the same method, but at the time of 
their. analysis an on-line computer system had been installed to assist 
in the cakui'ation· of amino acid concent rations .  No · dif ferences in 
concent rations could be related to the change in instrument�tion , but 
the new system did . not allow consis�ent estimations of cysteine , tau­
rine, or arginine. These values are consequent ly not available for the 
samples collected at one week of age . 
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Statistical analyses were performed with the �tatistical Analysis 
System (SAS 79 ) maintained at The University of Tennessee Computer 
Center ( 78 ) .  Effects of independent variables on plasma amino acid 
concentrations were analyzed by analysis of variance . ( 79 ) . Linear 
�egression was used . to generate equations predicting plasma amino acid 
concentrations as functions of the significant independent' variables . 
Pearson product-moment correlations were calculated to determine the 
relationships between gestational age and caloric and nitrogen intakes 
on the initial day of growth and between plasma branched chain· amino 
acid concentrations and growth and caloric intake . P values of O .  05 or 
less were considered significant . 
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C H APT E R  I V  
RESU LTS 
· Subjects 
The 2 1  prete rm infa nts inc l uded in  the i n i ti a l  phase of th i s  study 
a re descr i bed i n  Tab le 2 .  T he infants ' gesta tiona l . age  ra nged f�om 
2 7-36  weeks , w i th a mea n age of 3 1 . 2 ± 2 .  3 weeks .  A l l  had appropr i­
a te for gestationa l age b i rth weig hts rang i ng from 960-2 608 g ( mean = 
1 574 ± 432 g ) . There were 1 3  ma les and 8 fema les , 1 b l ack infant and 
2 0  ca ucas ian . T he sample i nc l uded one set of tw i n s  ( Sh l  and Sh2 ) ;  
the rest were s i ng l e  b i rth s .  A l l · i n fa nts su rv ived except on e ( Yoa ) 
w ho d ied at age 1 1  months of comp_l icat ions u n re lated to pa ren tera l 
i nfu s ion . 
Resu l ts at B i rth  
I mmed iate ly  a fter b i rth and before p lacenta l sepa ra tion m ixed 
u mb i l i ca l  co rd b lood was obta ined from 1 0  subfects . T he mea n , range , 
and sta nda rd deviat ion of p lasma ami no ac id  concentrat ions i n  these 
samp les is presented in Tab le  3 .  
Resu l ts I mmed iate ly Prior to Ami no Ac i d  
Infu sion and 24  Hou rs Later 
After an  in i ti a l  pe riod of  i n fus ion w ith so l u tion s _ conta i n i ng . on l y  
g l ucose and e lectrolytes , each i n fa nt received i ntravenous fl u ids  
conta i n i ng both a m i no ac ids  and g lucose as we l l  as  v i tami n s ,  mi nera l s  
a nd e lectro lytes . Composit ion o f  the standa rd sol ut ion i s  show n i n  
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TAB LE . 2 
Desc r iption of subjects 
I n fants Gestationa l age B i rthweight 
weeks g 
Dra 27 1 0 00 
Tab 28 960 
Z im  2 8  1 1 40 
Lov 29  1 2 00 
Pol 29  1 4 2 0  
Tap 30 1 1 40 
Jar  30  1 2 00 
Yoa 30 1 350  
Vnc 3 1  1 36 0  
Kop 3 1  1 62 0  
Ph i 3 1  1 6 2 0  
Seu 32 1 440 
God 32  1 6 00 
Dia 32  1 620  
Bws 32  1 6 60 
B i s  3 3  1 900  
Sh 1 33  1 7 60 
Sh2 33 · 1 790 
B ro 34 2 3 6 0  
Bow 35 2608  
C la  36  2 2 00 
Means 3 1 . 2 1 5 74  
SD 2 . 3  43 2 
Range 2 7-36 960-2608 
TA B LE 3 
Amino · ac id  concentrations in  umb i l ica l cord p l asma 
Am ino acid Mean SD Rang e 
mg / d i  mg / d i  mg / d i  
H i sti d i ne 1 . 39 0 . 5 3  0 . 74-2 . 3 2 
Orn ith i ne 1 .  40 0 . 6 1 0 . 57-2 . 2 2 
Lysine 4 . 32 1 .  2 7  2 . 89-6 . 5 7 
Arg i n i ne 1 .  06 - 0 . 43 0 . 77-2 . 08 
Ta u ri ne 2 . 5 9 1 .  17 1 . 3 1-4 . 8 6 
Aspa rt i c  ac id  0 . 36 0 . 05  0 . 16-0 . 74 
T h reon i n e 4 . 46 2 . 2 7 2 . 09-9 . 11 
Ser ine 1 .  9 1  0 . 57 1 . 3 0-2 . 9 0 w 
G lutamic  ac id 3 . 8 9 1 . 6 3  1 . 6 3-6 . 8 6 ....., 
Prol i ne 1 . 84 0 . 5 6 1 . 11-2 . 9 4 
G lyci ne 1 . 42 0 . 45 0 . 93-2 . 19 
A la n i ne 3 . 5 2 1 .  16 2 . 42-6 . 08 
Cy steine 0 . 6 9 0 . 4 3 0 .  2 6- 1 . 7 2  
Va l i ne 2 . 35 0 . 6 6 1 . 42-3 . 6 3 
Meth ion i ne 0 . 42 0 .  19  0 . 23-0 . 8 7 
l so leuc i ne 0 . 78 0 . 33 0 . 2 9-1 . 3 5 
Leuci ne 1 .  14 0 . 5 5 0 . 65 -2 . 4 8 
Tyro s i ne 1 .  11 0 . 27 o·. 73 -1. 12  
Pheny l a l a n ine 1 . 66 0 . 57 0 . 84-2 . 6 3 
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Tab le 4 .  T h i s  infu sate conta i n s  no ·ta u r ine , cystei ne , g lutam ic  ac id  o r  
a s.par�ic ac id . Postnata l age at the t ime am ino acid-su pplemen te� i n fu­
s ion began va ried from 2'4-75 hou rs . Al l  i n fants had an umb i l ica l  
a rtery c·atheter from wh ich b lood samp l es were d rawn just p rior  to 
i n i tiat ion ·of the i n fus ion and 2 4  hou rs later . No other intravenou s 
sol ut ions we re g iven du r i ng th i s  t ime . The mean and standa rd dev i ­
ations of the p l asma concentration s  of 1 9 · am ino aci ds  before i n fu s ion 
and 2 4  hou rs later a re presented in  Ta b le  5 .  
After 24  hou rs i n fus ion there was a s i g n i ficant increase in  p lasma 
concentration of i so leuci ne , leuc ine , a rg i n i ne , meth ion ine ,  g lyc ine , 
va l i ne ,  a la n i ne ,  ser ine , l ys i ne , th reon i ne ,  pro l i ne , and  pheny l a l a n i ne .  
Nonsign i ficant ( p  . > • 05 ) increases occurred i n  the concentration s o f  
orn ith i ne , aspartic ac i d , h i stid i ne , a n d  cyste ine , a n d  non sig n i fi c<:3nt  
· decreases occu rred i n  the concentration s of ta u ri ne , g l utamic ac id  and  
tyros ine .  
The ab sol ute change i n  am i no ac id  concentration ( concentrat ion 
a fter 24 hou rs i n fus ion m inus  concentration before i n fu s ion ) ,  the . per­
cent of  change in  p l asma concentrat ion ( a bso lute change / i n i ti a l  con- : 
centration ) and the d i recti on of ind iv idua l  change in  p lasma concentra­
t ions a re presented in  Tab le  6 .  Va r ious factors were postu lated to be 
. re lated to the infant ' s p lasma am ino ac id  concen trat ion after 2 4  hou rs 
i nfus ion and /or  to changes in concentration .du r i ng that i nterva l . 
Esti ma tion of the effects of gestationa l ag e ,  postnata l age ,  weig h t , 
ca lor ic  inta ke , am ino ac id  inta ke , and pre infu s ion concentrat ion were 
determ ined by two-way ana l ys is  of va·r iance . 
TABLE 4 
Compositi on of parenteral solut ion 1 
Component Concentration / d I Component _Concentration I di 
L-lsoleucine2 
L- Leucine 
L-Lysine 
L-Methionine 
L- Phenylalanine 
L-Threonine 
L-Tryptophan 
L-Valine 
L-Alanine 
L-Arginine 
L- Histidine 
L- Proline 
L-Serine 
L-Tyrosine 
Glycine 
72 mg 
94 mg 
72 mg 
40 mg 
44 mg 
52 mg · 
16 mg 
80 mg 
1 28 mg 
98 mg 
30 mg 
86 mg 
42 mg 
4 . 4  mg 
1 28 mg 
1 Prepared in hospital pharmacy. -
Dextrose 
Sodium 
Chloride 
Potassium 
Phosphate 
Magnesium 
Calcium 
3 Multivitamin 
Vitamin 8-12 
Folic acid 
Zinc 
Copper 
Chromium 
Manganese 
Calories 
2Amino acids supplied in 1 gm Aminosyn (Abbott Labor�tories , Chicago , Ill . ) .  
3MV I Pediatric (Armour Pharmaceutical s ,  Kankakee , 1 1 1 . ) .  
1 0  g 
3 mEq 
3 mEq 
2 . 2  mEq 
1 . 5 mM 
o .  2 5  mEq 
1 .  92 mEq 
0 . 5  ml 
1 0  mcg 
S O  mcg 
22  mcg 
5 . 5  mcg 
• 055  mcg 
. 44 mcg 
38 
w 
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TABLE 5 
Plasma amino acid 1 concentrat ions before amino ac id infusion 
and 24 hours -later 
Before infusion After 24  hours 
Mean SD N Mean SD N p 
mg/ di mg/ di . mg/ di mg/di  
l soleuci ne 0 . 46 0 . 2 8 2 1  0 . 9 4 0 . 79 20 . 0029  
Arginine 0 . 68 0 . 34 1 7  1 .  2 6  0 . 88 20 . 0 1 60 
Leuci ne 0 . 95 0 . 4 3 2 1  1 .  58  1 . 06 20 . 005 1 
Methionine 0 . 38 0 . 2 1  20 0 . 60 0 . 38 1 9  . 0096 
Val ine 1 . 40 . 0 . 5 7 2 1  2 ._ 1 1  0 . 8 2 20 . 0003 
Ornithine 1 .  1 3  0 . 87 20 1 .  2 4  0 . 47 20 . 061 1 w 
U1 
G lyc ine 2 . 3 9 1 .  1 2  2 1  3 . 44 1 . 88  2 1  . 0029  
Alanine 2 . 08 1 . 43 2 1  2 . 63 1 .  56  2 1  . 0039 
Serine 1 .  93 0 . 8 5 2 1  2 . 8 2 1 .  66 2 1  . 0042 
Lysine 1 . . 80 0 . 73 20 2 . 44 1 .  08 2 1  . 0020 
Threoni ne 3 . 1 2  1 .  70 2 1  3 . 9 6 2 . 45 2 1  . 0 346 
.prol i ne 1 .  98 1 . 26  2 1  2 . 43 1 .  1 1  2 1  . 0088 
Aspart i c  acid 0 � 34 0 . 25 2 1  0 . 3 6 0 . 23 1 9  . 5 4 2 1  
Histidine 2 . 08 1 . 04 20 2 . 40 1 .  1 1  2 1  • 1 809 
Phenylalanine 1 .  1 8  0 . 46 2 1  1 .  40 0 . 52 2 1  . 0 1 62 
Cysteine · o . 46 0 . 2 4 1 5  0 . 5 9 0 . 44 1 6  . 61 87 
Tauri ne ·2 .  49 ·  1 .  1 5  1 3  2 . 36 1 .  06 1 3  . 0662 
Glutami c  acid 4 . ·70 3 . 70 2 1  3 . 70 2 . 47 2 1  . 0969 
Tyrosine 1 .  98 1 .  1 4  . 2 1  1 .  8 3  1 . 06 20 • 1 561 
--
1 Inc luding the sulfon ic  amino acid taur ine. 
Amino ac i d  
l so leuc i ne 
A rg i n i ne 
Leuci ne 
Meth ion i ne 
Va l i ne 
O rn ith ine  
G lyci ne 
A la n i ne 
Se r ine  
Lys i ne 
T h reon i ne 
Prol i ne 
Aspa rtic ac id  
H i sti d i ne . 
Pheny l a l a n i ne 
Cyste i ne 
Tau ri ne 
G l utam ic  ac id  
Ty ros ine  
TAB LE 6 
Changes in  a m i no ac i d  concentrat ion in  the fi rst 2 4 · hou rs of i n fus ion 
Abso lute 
clia nge 1 
mean 
mg / d i  
0 . 50 
0 . 59 
0 . 65 
0 . 22 
· 0 . 74 
0 . 27 
1 . 06 
0 . 54 
0 . 89 
0 . 69 
0 . 84 
0 . 46 
0 . 03 
0 . 35 
0 . 22 
0 . 1 3  
0 . 1 3  
-0 . 99 
-0 .26 
% 
cha nge 2 
mean 
1 36 
1 35 
83 
73 
66 
59 
50 
47 
46 
45 
35 
34 
30 
2 9  
27 
27 
1 
-3 
-9 
Decrease3 
n 
1 
2 
5 
1 
2 
6 
4 
4 
3 
3 
4 
4 
· 8 
6 
5 
5 
2 
1 2  
13 
No 
- change3 
n 
2 
1 
1 
1 
3 
0 
1 
0 
3 
2 
3 
4 
0 
2 
0 
1 
3 
. 1 
0 
1 Concentration · after 2 4  hou rs i n fu s ion - concentrati on before i n fu s ion . 
2 Abso lute change I in it ia I concentrat ion . 
l ncrease 3 
n 
1 7  
1 4  
1 4  
1 6  
1 5  
1 3  
1 6 
1 7  
1 5  
1 5  
1 4  
1 3  
1 1  
. 1 2  
1 6  
7 
6 
8 
7 
3 Decrease = number of  i n fa nts w hose p lasma a m i no aci d con centra ti on dec reased i n  the fi rst 
2 4  hou rs of  ami no acid i n fu s ion . No  cha nge = number w hose concentrat ion changed by l ess 
than 5% . I ncrea se = number whose con centrat ion i ncrea sed . 
w °' 
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Plasma amino ac id concentrations after 24 hours infusion were 
d irectly  associated with pre in fusion plasma leve ls of leucine, iso leucine, 
val ine, tyrosine, glycine, glutami� ac id, methionine, l ysine, h istid ine, 
threonine, serine, prol in.e, aspartic acid and pheny lalanine (Table 7). 
Post 24 hour infusion concentration of phenylalanine was also associ­
ated with postnata l age, younger infants tend ing to have higher pl�sma 
pheny lalanine concentrations . • 
The absolute change in plasma phenylalanine concentration was 
simi lar ly associated with postnata l age (Table 8) . Prol ine, aspartic 
acid , glutamic ac id and phenyla lanine were the only amino ac ids whose 
preinfus ion plasma levels had signifi�ant effects on absolute change in 
plasma concentration in the first 2 4 hours of in fusion. In these 4 
instances higher preinfusion concentrations were associated with sma l i ­
er increases in plasma concentration. 
The percent of change in plasma concentration . of isoleucine, 
va l ine, phen.y lalanine , and h istid ine also tended t� vary inverse ly  
·with 
preinfusion concentration (Table · g) . The percent of increase of val ine . 
· concentration in the first 24 hours was associated with caloric intake 
and gestational age as we l l  as with pre infusion concentration. Plasma 
val ine concentration tended to increase · more in more mature infants . 
and in those with lower ca loric intakes. The percent of increase in  
plasma isoleucine was also greater in  infants w ith greater gestationa l 
age . 
Neither weight at the beginnin.g of amino ac id infusion , nor the 
intake of each amino acid , . nor the infant's sex were ever significantl y 
TAB LE 7 
Ana lysis of variance summa ry for factors a ffecti ng amino ac id concentration 
a fter 24 hours of ami no ac id i nfus ion 
Amino acid I ntercept S lope Sum of squa res F-va lue p 
Pre infus ion concentration : 
Leucine 0. 377542 1 . 285439 5. 5 9767986 6 . 92 . 0 1 70 
l so leucine 0. 045 574 2. 003 1 82  5. 0 1 80 1 260 1 3. 38 . 001 8 
Va l ine 1 . 1 41 767 0. 704507 2. 9641 1 841  5 . 38 . 0 323 
Tyros ine 0. 364989 0. 6845 20 1 2. 1 5358264 23 . 53 . 0001  
G lyc i ne · 0. 8 1 88 1 1 1 . 099041 3 0. 1 1 522260 1 4. 1 8  . 001 3 
G lutamic acid 1 . 499299 0 . 465470 47. 1 0 9636 09 1 2. 1 2  . 0025 
Methion ine 0. 276946 0. 866330 0. 59754204 5. 33 . 0347 w 
Lys ine 0. 8 1 08 5 2  0. 9301 20 8. 8221 76 0 1  1 1 . 40 . 0034 
H i st id i ne 1 . 3 5663 1  0. 5 1 5445 5. 41 05 1 949 5. 05 . 0375 
Threon ine 0. 8838 52  0. 995335  6 2. 1 1 9726 1 9 20. 24 . 0002 
Ser ine 0. 635086 1 . 1 426 1 2  22. 1 3 503541  1 2 . 97 . 0 01 9 
Prol i ne 1 . 2539 1 0 0. 606773 1 1  · • 607286 78 1 7. 60 . 0005 
Aspa rtic acid 0. 1 54573 Q. 6 1 6 1 24 0. 4501 4029 1 4. 88 . 001 3 
Phenyla lan ine 1 . 376448 0. 705405 2. 02803860 1 8 . 9 1  . 0004 
Postnata l age : 
Phenyla l an ine 1 . 376448 -0 . 0 1 7255  0. 87769986 8. 1 9  . 0 1 04 
TA B LE 8 
Analysis of variance summary for factors affect i ng absolute change i n  p lasma 
amino acid levels i n  the fi rst 2 4  hours of amino acid  infusion 
Amino acid I ntercept 
Prei nfusion concentration : 
Pral i ne 
Aspartic  aci d  
Glutamic ac id 
Pheny la  la  n ine 
Postnatal age : 
Phenylalan i ne 
1 . 253 9 1 9 
0 . 1 545 73 
1 . 499299  
0 . 935636 
0 . 935636 
S lope 
-0 . 393226  
. -0 . 3838 75 
- 0 . 534529  
-0 . 0 1 55 36 
-0 . 0 1 5022  
Sum of  squares 
4 . 87488628  
0 . 1 7474029  
62 . 1 252 9324  
0 .  72952701  
0 . 58936237  
F-value 
7 . 3 9 
5 . 78 
1 5 . 9 8 
6 . 07 
5 . 48 
p 
. 0 1 3 6 
. 0279 
. 0008 
• 0235 
. 0335 
w 
� 
TAB LE 9 
Ana lys is  of va r iance summa ry for fa ctors a ffecti ng percent _of  change 
in p la sma am ino ac i d  level s i n  the fi rst 
24 hou rs of a m i no acid i n fu s ion 
Am i no ac id  I ntercept S lope Sum of squa res F-va l ue p 
Prei n fu s ion concentration : 
l so leucine -6. 948225 -3. 2361 95 1 o .  69872200 1 0. 02 • 0231 
Va l i ne -1 . 1 1 5742 - 1 . 81 4252 22. 1 5796342 1 0. 40 . 0061 
Pheny l a l an i ne 1 .  9i 8306 -0 . 59960 1 1 .  465291 1 5  7. 90 ·• 0 1 1 6· 
H i st id i ne 0. 832471 -0.258701  1 . 36292423 6 .  1 7  . 023 1  
Gestat iona I age :  
l so leuc i ne -6. 948225 0. 341 1 68 1 0. 7 381 6784 1 0. 06 . 0059 
Va l i ne - 1 . 1 1 5742 0. 426272 1 2. 98577452 6. 1 0  • 0270 
Ca lor ic  inta ke : 
Va l ine  - 1 . 1 1 5742 -0. 1 460 1 2  1 4. 487331 02 6. 80 . 0206 
Postnata l age : 
Pheny l a l a n i ne 1 . 91 8306 -0. 020259 1 . 20993589 6. 52 . 0 1 99 
4 1  
a ssoc iated w ith p lasma amino ac i d  concentration a fter 24 hou rs i n fus ion 
o r  w ith changes in  that concentration , e ithe r a bso lute or percen, .  
Each i n fant 's. am ino ac id a n d  ca l o ric  i n ta ke in  the fi rst 2 4  hours  
. of  i n fu s ion was  ca lcu lated from the vol ume and compos iti on of  the so l u ­
t ion i n fu sed . Vo l ume va ried as  much as 2 3 0 %  ( range = 75 - 1 71  m l /  2 4  
hou rs ) . Tota l inta ke was d iv ided by body weig ht at the beg i n n i ng of 
i nfus ion to determin e  the i n ta ke in  mg / kg / day for each am ino aci d 
( Ta b le 1 0 ) . I nta kes were compa red w ith those recommended by Steg ­
i n k ,  G had im i , Poh landt , B u rger and Snyderman ( 1 0- 1 3 ) . The major ity 
of i n fa nts received less than the m i n imum recommended inta ke of a l l 
am ino ac ids  except methion i ne , a la n i ne ,  g lyc i ne , pra l i ne ,  a n d  i so leu­
c ine . Meth ion i ne was the on l y  amino ac id rece ived in  amounts g reater 
tha n  the max i mum recommen ded , i . e . , 5 infants received more than  the 
max imum meth ion i ne recommended w h i l e  1 6  had inta kes w ith i n  the rec-
. ommended range . I n  contrast , no i n fa nt recei ved even the sma l l est 
recommended a mou nt of leuc i ne , lys i ne , phen y l a la n ine , tyros i ne or 
h isti d i ne in  the fi rst 24  hou rs of  infus ion . For each of the other 
a m i no ac ids  some i nfa nts had inta kes w ith i n  the recommended rang e 
w h i le others had less than the mi n imum recommended inta ke . Ca lor ic  
inta ke ranged from 1 9-5 1 kca l / kg/ day w ith a mean of 35  ± 1 0  kca l / kg /  
day . 
Change i n  p lasma concentration pe r mg i nta ke in  the fi rst 2 4  
hours o f  infus ion was calcu lated for each amino a·c id  ( Ta b le 1 1 ) .  The 
rate of change was extreme ly va riab l e .  For ex�mple , the increase i n  
concentrat ion per m g  of ser i ne i n fu sed w a s  a lmost 5 0  t imes g reater 
.Amino acid 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Threonine 
Valine 
Alanine 
Arginine 
Glycine 
Tyrosine 
Histidine 
Proline 
lsoleucine 
Serine 
Tryptophan 
TAB LE 1 0  
I ntake of amino acids in first 2 4  hours of infu sion 
compared to literature recommendations 
Mean SD Range l -6 Recommended 
mg/ kg/day mg/ kg/day mg / kg/day mg/ kg/day 
87 2 2  47- 1 2 1  1 25-400 
67 1 7  36-99 1 20-334 
37 9 20-54 1 5-45 
4 1 1 0  22-57  59- 1 04 
48 1 2  2 6-7 1  60- 1 50 
74 1 9  40- 1 09 80-200 
1 1 8 30 64- 1 74 1 00-700 
9 1  23  49-1 34 1 1 0-250 
1 1 8 30 64- 1 74 50-255  
4 1 2-6 1 3-79 
28 7 1 5-41  50-1 20 
80 20 43- 1 1 7  50- 1 35  
67 1 7  3 6-99 60-200 
39  1 0  2 1 -57 50-1 00 
1 5  4 8-2 3 30-1 20 
7 <Rec Rec 8 9 >Rec 
2 1  0 0 
2 1  0 0 
0 1 6  5 
2 1  0 0 
1 8  3 0 
1 5  6 0 
8 1 3  0 
1 5  6 o · 
0 2 1  0 
2 1  0 0 
2 1  0 0 
2 1 9  0 
8 1 3  0 
1 9  2 0 
2 1  . - . 0 0 
1 For each amino acid the first number is the smallest of · the mm1mum recommended intakes 
of 4 investigators .  and the second is the largest of _the maximum recommended intakes of thes� 
investigators. 
2Pohlandt , F. ( 1 979 )  Studies on the requirement . of amino acids in newborn infants receiv-
ing parenteral nutrition. I n :  Nutrition and Metabolism of the Fetus and I n fant ( Visser , 
H . K. A. , ed . ) ,  pp. 341 -364 , Martinus Nijhoff , the Hague. 
· .s:::: 
....., 
TABLE 1 0  (continued) 
3surger, U .  & Wolf, H .  ( 1976) Investigations on the utilization of parenterally administered 
amino acids by premature and hypotropic neonates . Europ . J .  Ped iatr . 122, 169-175 . 
4Ghad imi, H .  (1975) Newly devised amino acid solutions for intravenous administration .  
In: Total Parenteral Nutrition: Premises and Promises (Ghad imi, H . , ed . ) ,  pp . 393-442, John 
Wiley & Sons, New York . 
5Stegink, L .  o' .  (1975) Development of a crystalline amino acid mixture for parenteral 
alimentation of young ch ildren . In: Intravenous Nutriti on in the H igh Risk Infant (Winters, 
R.  W .  & Hasselmeyer, E .  G. , eds . ) ,  pp . 411-420, John Wiley & Sons, New York . 
6Snyderman, S .  E .  (1975) Amino acid requirements . In : . Intravenous ·Nutrition in the High 
Risk Infant (Winters, R.  W.  & Hasselmeyer, E . G. , eds . ) , pp . 205-21 4, John Wiley & Sons, 
New York . 
7 < Rec = number of infants receiving less than minimum recommended intake . 
8Rec = number of infants with intakes within the recommended range . 
9> Rec = number of infants receiving more than the maximum reco�mended intake . 
.i:= 
w 
Am ino ac id  
Ser ine 
Threon ine  
H istid i ne 
Lys i ne 
Va l i ne 
G lycine 
l so leuci ne 
Leucine 
Arg i n ine 
Methion i ne 
Prol i ne 
Pheny la la n i ne 
A lan i ne 
TA B LE 1 1  
Change in  p lasma am ino acid concentrati on per mg intake 
i n  the fi rst 2 4  hours of i n fus ion 
Change In ta ke 
mean mean 
mg / d i  mg / day 
0 . 89 5 3  
0 . 84 65 
0 . 35 38 
0 . 6 9 9 1  
0 . 74 1 00 
1 . 06 1 6 1 
0 . 50  90 
0 . 65 1 1 8  
0 . 59 1 2 3 
0 . 2 2 so  
0 . 46 1 08 
0 . 22 55  
0 . 54 1 60 
Change /mg 
I nta ke 
mean 
. 01 68 
. 0 1 29 
. 0092 
. 0076 
. 0074 
• 0066 
. 0056  
J:: 
J:: 
. 0056 
. 0048 
. 0044 
. 0043 
. 0040 
. 003 4 
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than that of alanine. The effects of amino acid intake were further 
analyzed by comparing the rates of change in plasma levels o� amino 
acids infused in similar amounts ( Table 12 ) .  Over the range of 
intakes received by the·se infants, changes in plasma concentration do 
not appear to bear a consistent direct relationship to intake . While 
similar rates of change occurred in methionine and phenylalanine and 
in leucine and arginine, rates were significantly different for the iso­
leucine-lysine and alanine-glycine pairs even though their intakes were · 
identical . 
Concentrations of plasma amino - acids after 24 hours of infusion 
were compared with those of ad libitum breast fed term infants (80 ) 
and with the concentrations of the preterm fetus as reflected by umbil­
ical cord concentrations determined in this laboratory ( Table 13 ) .  The 
choice of reference data used for comparison is problematic . · The goal 
of nutr itional support is to provide the infant with nutrients essential . . 
for optimal growth and development while at the same time protecting 
the vulnerable nervous system from potentially damaging eleva�ions .in 
amino acid levels . There is, therefore, a need for estimating the 
minimal level reflecting adequate nutrition and the maximum level 
reflecting safe , nontoxic concentrations . 
Although the preterm infant is a . different biological entity , and 
the composition of milk from mothers of prematures differs from that of 
mothers who deliver at term ( 81) ,  plasma concentration of amino acids 
of term breast fed infants was selected as one standard. I t  is pre­
sumed that these breast fed babies were being optimally nourished and 
Ami no aci d 
l soleuci ne 
Lys i ne 
Ala n i ne 
G lyc ine 
Leuc ine 
Arg i n i ne 
Methion i ne 
Pheny la la n i ne 
TAB LE 1 2 . 
Compar i son of cha nge in  p la sma ! eve ls  of amino ac ids  
w i th  s im i lar  i ntravenous inta kes 
I n ta ke Plasma change per mg in ta ke 
mg / d i  i nfusate mg / d i  
72 . 0055 
72 . 0076 
1 2 8 . 0034  
1 28 . 0066 
94 . 0055 
98 . 0048 
40 . 0047 
44 . 0040 
p 
< . 0 1 
< . 00 1  
NS 
NS  
J:: 
en 
Amf oo ad d 
Hhti d f oe 
Orni tM ne 
Lys i ne 
Phenyl a l ani ne 
Tyrosi ne 
Leuci ne-
1 sol eud ne 
MetM oni ne 
Va l f oe 
Al anf oe 
G lyci ne 
Gl utami c  aci d 
Sed ne 
Threoni ne 
Aspart i c  aci d  
Prol i ne 
Cystef oe 
Taud ne 
Argi nf oe 
TABLE 1 3  
Compa ri son of pl asma ami no aci d concentrati ons i n  study i nfants after 24 hours 
Subjects 
Range 
mg/d l 
0 . 96-4 .96 
0 .4 1 -2 . 34 
0 .5 1 -5. 48 
0 .57-2 .7 1 
0 . 56-4. 46 
0 .34-5 . 1 0  
0 . 2 1 -3 .79 
0 . 1 6- 1 .69 
0 . 62-4 . 1 2 
0 . 83-7.85 
1 . 69-8 . 36 
0 .86-1 0. 1 
0 . 54-7. 29 
0.50-1 0 .93 
o .  1 o-o .  92 
0. 66-5 .47 
0 . 08- 1 . 99 
0 . 69-4 .86 
0 . 58-4 . 1 2  
of i nfusion ,  breast fed i nfants and umbi l i cal  cord bl ood sampl es 
Breast fed
1 
Range 
mg/dl 
o .  73-1 . 63 
0 .73-1 . 45 
1 . 25-2 . 69 
0 .49- 1 . 06 
0 . 60-2 . 28 
0 .64-1 .59 
0 . 26-0 . 68 
0 . 1 9-0. 34 
0 . 88-1 . 89 
1 . 1 9-3 . 3 1 
1 . 1 0-2 . 02 
4 .78-1 2 . 1 9  
0 . 74-2 . 1 5  
0 .61 -1 . 72 ---- ----
1 .07-4 . 80 
0 . 79-1 . 42 
0. 3 1 -1 . 09 
0 . 51 -1 . 2 1 
<Mf o
2 = 
0 
3 
1 
0 
1 
2 
1 
1 
1 
1 
0 
1 5  
1 
1 --
2 
1 2 
0 
0 
--
2 
>Max2 Cord b l ood
3 
Range 
mg/d l 
6 1 5  0 . 74-2 . 3 2  
1 0  7 . 044-6. 2 1 
1 4  6 2 . 07-6 .57  
4 1 7 0 . 89-2 . 63 
1 5  4 0 . 69-1 . 7 2 
1 3  6 0 .8 2-2 . 48 ·  
8 1 2 0 . 29-1 . 35 
3 1 5  0 . 2 3.-0 .  87 
6 1 3  1 . 4 2-3 . 63 
1 6  4 1 .93 -6. 08 
6 1 5 0 . 61 - 2 . 1 9  
6 0 1 .63-9. 61 
6 1 4 0 . 87-2 . 90 
1 1 9  2 . 09-9 . 1 1  - - - - 0 . 1 6-1 . 1 5  
1 8 1 0 . 93-2 . 75 
4 0 0 . 26-1 . 7 2 
1 1 2 1 .3 1 -4 . 86 
1 4 6 0 . 61 -1 . 40 
<Mi n
4 
0 
1 
7 
3 
2 
2 
1 
2 
3 
6 
0 
4 
2 
4 
4 
2 
1 5 
2 
2 
=
4 
>Max 4 
1 3  8 
1 9 0 
1 4 0 
1 7  1 
1 2 6 
1 6 3 
1 6  3 
1 2 5 
1 6  1 
1 4 1 
3 1 8 . 
1 6 1 
1 3  6 
1 5  2 
1 5  0 
1 3 . 6 
1 0 
. 1 1  0 
1 3  5 
1
Ti kanoj a ,  T .  ( 1 982 ) Pl a.sma amf oo aci ds f o  term neonates after a feed of human m ; J k  or formul a .  Acta Paediatr . Scand . I!, 
39 1 -397 . 
2< Mi n = number of i nfants wi th l evel s l ess than mi n imum i n  breast fed term i nfants . = i s  number wi thi n range .  > Max = 
number e�ceedi ng maxi mum . 
3
Pl asma ami no ac i ds from umbi l i ca l  cord sampl es f rom 1 6  premature i nfants ( 27-35 weeks gestati on ) .  Unpubl i shed data from 
thi s l aboratory . 
4
< Mi n = number of i nfants wi th l evel s l ess than mi ni mum i n  premature cord pl asma . = i s  number wi th i n range . > Max 
number exceedi ng maxi mum . · 
� 
....... 
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wou ld have no p lasma · concentrat ion i nd ica ti ve of an am ino ac id  defic i­
ency or tox ic i ty . I t  i s  l i kew i se presumed that the am ino aci d . supp l y  
to the fetus i s  opti ma l  a t  each gesta tiona l age ,  ma k i ng umb i l ica l p l asma 
concentrations a n  appropriate sta nda rd . T herefore , cord samples from . 
1 6  prematu re in fants , i nc lud i ng 1 O study i n fants , ( gesta tiona l age 
2 7-35  weeks ) ,  obta i ned immed iate ly a fter b i rth and before p lacenta l 
sepa ra tion we re ana lyzed . U mb i l i ca l  p lasma am ino ac id  concentrations 
of these preterm i n fa nts were used as  a second reference . I t  i s  rec­
ogn i zed that the fetus has a net producti on of  g l utam i ne , g lyc ine , a �d 
seri ne resu l ti ng in  the i r  transfer back to the p lacenta or mother v ia 
t he umb i l i ca l  a rtery and , the refore , an i ncrea se i n  the i r· concentration 
in umb i l i ca l  cord p la sma ( 82 ) . W ith the exception of these . th ree ami no 
a ci d s , umb i l i ca l  cord concentrat ion i s  thoug ht to reflect feta l su pp ly  
a nd be  devoid  of  tox ic  a m i no ac id  concentra tion s .  A lthough there i s  
. w i de va riab i l i ty i n  the concentrations reported i n  t�ese two standards , 
i t  ca n be genera l l y  stated that umb i l ica l  cord p la sma leve l �  are h ig he r  
t h a n  level s found i n  b reast fed i n fa nts ( exceptions be i ng prol i ne , 
g lu tami c  ac i d , th reon i ne and ty ros i ne ) . M i n i ma l  p lasma l eve l s  of ami no 
ac ids in · b reast fed i n fa nts a re ,  conseq uen tl y ,  probab ly  a better  stan­
da rd for assess i ng adeq uacy w h i le max i mum concentra tion s i n  umb i l ica l 
co rd samples and / or b reast fed i n fants a re acceptab le  for determ i n i ng 
poss i ble  tox i ci ty . 
Even at  the low i nta kes received by infa nts in  the fi rst 2 4  hou rs 
of i n fu s ion , seve ra l a m i no acids were found i n  concentra ti .ons exceed ing 
the  max imum observed i n  e i ther b rea st fed te rm i n fants or prematu re 
49 
umbi lical p lasma (Table 13) . Several infants had comparatively  high 
concentrations of glycine, methionine, arginine, histidine, phenyl­
alanine, and serine. Conversely, very few of the infants could be 
considered to have an adequate cysteine level ( 1 of 16 when compared 
to cord values and 4 of 16 when compared to breast fed infants ) .  
Results at One Week of Age 
The eleven infants maintained on· total parenteral nutrition with no 
oral supplementation for at least one week are described in Table 14. 
This group inclu_des 9 of ·the original sample and 2 additional infants 
( Per and Dal ) .  Not surprisingly, these infants tended to be sma l l er 
and younger in terms of gestational age than the infants in the origi­
nal sample who had begun enteral feedings prior to the eighth post­
natal day . Gestational age for the infants evaluated at one week of 
age ranged from 27 to 36 weeks with a mean age of 30. 8 ± 2. 8 weeks. 
Their weight at birth was appropriate for gestational age and averaged 
1493 ± 397 g (range = 970-2200 g ) .  This group included 7 males and 4 
fema.les and one set of t':Yins ( Sh1 and Sh2 ) .  
Blood samples from heel puncture sites were obtained on the 
eighth day of life ( age one week ) and analyzed .as previously de­
scribed. Results are presented in Table 15. 
Each infant's amino acid a·nd ca loric intake in the· 24 hours prior 
to sample col lection was calculated from the volume and composition of 
the solution infused. Amino acid concentration in the infusate was 
either as described in Table 4 ( p. 34 } [ one gram of the crysta l line 
L-amino amino acid mixture Aminosyn ( Abbott Laboratories, North 
I nfants 
Per 
Dra 
· Dal 
Lov 
Yoa 
Vnc 
Kop 
Sh l 
Sh2 
B is  
Cla 
Means 
SD 
Range 
5 0  
TAB LE 1 4  
Subjects receiving total parenteral nutrition 
exclusively for at · 1east one week 
Gestational age B i  rthweight 
weeks g 
27 970 
27 1 000 
29  · 1 1 60 
29  1 200 
30 1 460 
3 1  1 360 
31  1 620 
33 1 7 60 
33 1 790 
. 33 1 900 
36 2200 
30 . 8  1 493  
2 . 8  397 
27-36 970-)200 
TABLE 1 5  
Plasma amino acid concentrati ons at one week of ·age 
Amino ac id  Mean SD Range 
-
mg/ di mg/ di mg/di 
H istidine 2 . 2 9 0 . 43 1 • 54-2 . 77 
Ornith ine 3 . 48 1 .  27  2 . 2 1 -6 . 20 
Lys ine 4 .  1 0  1 . 36 2 . 34-6 . 86 
Phenylalanine 1 .  2 1  0 . 24 0 . 86-1 . 57 
Tyr�sine 1 . 23  0 . 4 1 0 .  73- 1 . 8 2  
Leuc ine 1 .  4 1  0 . 20 1 . 06-1 . 6 9 
l soleuc ine 1 . 00 0 . 20 0 . 64- 1 . 4 1 
Methionine 1 .  1 0  0 . 34 O .  70-L 43 
Val ine 2 . 52 0 .  52  1 . 46-2 . 99 
Glyci ne 3 . 97 0 . 97 ' 2 . 2 3-6 . 2 1 
u, -
Alani ne · 2 . 47 0 . 6 4 1 . 39-3 . 70 
Glutamic  ac id 5 . 32 1 .  26  2 . 94-6 . 94 
Se.r ine 2 . 2 9 0 . 44 1 . 42-3 . 00 
Threonine 3 . 34 1 . 30 1 . 49-6 . 4 1 
Aspartic  · ac id 0 . 43 0 . 33 0 . 07- 1 . 0 6 
Prol i ne 2 . 86 0 . 80 1 . 64-4 . 22 
5 2  
Ch icago , 1 1 1 . ) pe r d i  i nfusate ] o r  w a s  increased b y  add i ng 1 .  8 g o f  
Aminosy n /d l . Re lat ive concentrat ion o f  am ino ac ids d i d  n ot d i ffer 
however ;  for example inta ke of g lyci ne and a la n i ne rema i n ed eq ua l , 
etc . Tota l am ino ac id i nta ke i n  the 24  hou rs preced i ng samp le  co l lec­
t ion was d i v ided by the weight at one week to determi ne  i nta ke i n  
mg / kg / day for each am ino ac id ( Ta b le 1 6 ) .  I nta kes were aga i n  com­
pa red w i th the recommendations of  Poh landt , B u rger , Steg i n k , Gha­
d i m i , and Snyderman ( 1 0- 1 3 ) . I n  contrast to the i nta kes in the fi rst 
24 hou rs of infus ion , the i nta ke of most am ino ac ids  was now w ith i n  
the recommended range for most i nfants . The most obvious exception 
was meth ion i ne wh ich was i n fused i n  excess of  the max i mum recom­
mended amou nt in a l l  1 1  i n fants . I n  some ca ses th i s  excess was 
ma rked ; for example  5 i nfants recei ved more than tw ice the max imum 
recommended inta �e and one 3 t imes . Eig ht ( 8 )  of the 1 1  i n fants a l so 
had i n ta kes exceed i ng the max i mum . recommended for pro l i ne ,  7 
exceeded max i mum for g lyci ne and 5 each for · se r ine and pnen y l a lan ine . 
These : very h igh i nta kes were at least pa rtia l ly refle�ted i n  p_ la sma 
a m i no ac id concentrations at one week ( Tab le  1 7 ) . A l l  1 1  i n fants had 
h igher p lasma g lyc in� concentrations  than the max imum reported i n  
e i ther breast fed term i n fa nts or prematu re umb i l ica l cord samp les . 
Meth ion i ne l eve l s  ( measu red . i n  on ly  6 babies becau se of techn ica l  prob­
lems ) exceeded max imum leve l s obta ined from breast fed i n fa nts in a l l  
cases and exceeded the max i mum leve l o f  cord p la sma i n  4 of 6 i n fa nts . 
Ser ine  concentration exceeded the max imum observed i n  the b rea st fed 
standard i n  8 of the 1 1  i nfants , but the g reat major ity ( 1 0  of 1 1 )  were 
TABLE 1 6  
I ntake of amino acids at one week compared to literature recommendations 
Amino acid 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Threonine 
Valine 
Alanine 
Arginine 
Glycine 
Tyrosine 
Histidine 
Proline 
l soleucine 
Serine 
T ryptophan 
Mean 
mg/kg/day 
202 
1 55 
86 
94 
1 1 2 
1 72 
274 
21 0 
274 
35 
65 
1 8 5 
1 55 
92 
34 
SD 
mg/ kg/day 
61 
47 
26 
28 
34 
52 
82 
63 
82 
1 1  
20 
56 
47 
28 
1 0 
Range 
mg/kg/day 
123-3 1 6  
94-243 
52-1 35 
57- 1 48 
68- 1 76 
1 05-269 
1 67-429 
1 28-328 
1 67-429 
-21 -5 5 
40-1 0 1  
1 1 2-289 
94-243 
54-1 44 
21 -54 
l -6 7 8 9 Recommended <Rec Rec > Rec 
mg/kg /day 
1 25-400 
1 2 0-334 
1 5-45 
59- 1 04 
60-1 50  
80-200 
1 00-7 00 
1 1 0-250  
50-2 5 5  
1 3-79 
50-1 2 0  
50- 1 35 
60-200  
50- 1 00 
30- 1 2 0  
1 
3 
0 
1 
0 
0 
0 
0 
0 
0 
3 
0 
0 
0 
4 
1 0  
8 
0 
5 
1 0  
7 
1 1  
8 
4 
1 1  
8 
3 
1 0  
6 
7 
0 
0 
1 1  
5 
1 
4 
0 
3 
7 
0 
0 
8 
1 
5 
0 
1 For each amino acid the first number is the smallest of the minimum recommended intakes 
of 5 investigators and the second is the largest - of the maximum recommended intakes of these 
investigators . 
2Pohlandt, F .  ( 1 979) Studies on the requirement of amino acids in newborn infants 
receiving parenteral nutrition . I n :  Nutrition and Metabolism of the Fetus and I nfant ( Visser, · 
H. K .  A. , ed . ) , pp . 341 -364 , Martinus Nijhoff , the Hague . . .  
U1 
w 
TA B LE 1 6  ( conti n ued ) 
3 B u rger ,  U .  & Wo lf ,  H .  ( 1 976 ) I nvestigations on the u t i l i za tion of  pa rente ra l l y  adm i n istered 
a m i no acids by prematu re and hypotropi c  neonates . Eu rop . J .  Ped i at r .  1 22 ,  1 69- 1 75 . 
4G had im i ,  H .  ( 1 975 ) New l y  dev i sed am i no ac id  sol ut ions for i ntravenous admi n istratio·n .  
I n :  Tota l Pa rentera l  Nutr ition : Premi ses and Promi ses ( G had i mi , H . , ed . ) ,  pp . 393-442 , John 
Wi l ey & Son s ,  New York . 
5 steg in k ,  L .  D .  ( 1 975 ) Deve lopment of a crysta l l i ne am i no ac i d m i xtu re for pa ren tera l 
a l i mentation of young ch i ldren . I n :  I ntravenou s Nutr i ti on i n  the H ig h  R i s k  t n fa nt ( Wi nters , 
R .  W .  & Hasse lmeyer , E .  G . , eds . ) ,  pp . 4 1 1 -420 , John Wi l ey & Son s ,  New Yor k . 
6Snyderman , · s .  E .  ( 1 975 ) Am i no ac id requ i rements . I n :  I ntravenous N utr i t ion in  the H ig h  
R i s k  I n fant  ( Wi nters , R .  W .  & Hasse l meyer , E .  G . , ed s . ) ,  pp . 2 05 -2 1 4 ,  John Wi ley & Sons , 
New York . 
7 < Rec = number of i n fants rece iv ing less than m i n i mum recommended inta ke .  
8 Rec = number o f  in fants w i th i n ta kes w i th i n  the recommended range . 
9> Rec = number of i n fa nts rece iv i ng more than the max i mu m  recommended inta ke .  
U'1 
.,I::' 
Ami no aci d 
Hi s ti d f oe 
Orn; thi ne 
Lysi ne 
Pheny l a l an i ne 
Tyrosi ne 
Leuci ne 
l sol euc i ne 
Meth ion i ne 
Val i ne 
Al ani ne 
Glyc i ne 
Gl utamk aci d 
Seri ne 
Threoni ne 
Asparti c  aci d  
Prol i ne 
TABLE 1 7 
Compar i son of pl asma ami no aci d concentrati ons i n  study ; nfants at one week , 
breast fed i nfants , and umb ; l f ca l  cord b l ood sampl es  
Subjects Breast fed
1 
<Mi n
2 =2 2 >Max Cord b lood
3 
<M; n4 
Range 
mg/d l 
1 . 54- 2 . 77 
2 . 2 1 -6.20  
2 . 34-6 . 86 
0.86- 1 .57 
0 . 73- 1 . 8 2  
1 .06-1 .69 
0 . 64- 1 . 4 1 
0.70- 1 .43 
1 .46- 2 . 99 
1 . 39-3 .70 
2 . 23-6. 2 1  
2 . 94-6.94 
1 . 4 2-3 .00 
1 . 49-6.41  
0 . 07- 1 . 06 
1 . 64-4 . 22 
Range 
mg/d l 
0 . 73- 1 . 63 
0 .73-1 .45 
1 . 25-2 . 69 
0 .49-1 . 06 
0 . 60-2 . 28 
0 .64-1 .59 
0 . 26-0. 68 
0 . 1 9-0. 34 
0 . 88-1 . 89 
1 . 1 9-3 . 3 1  
1 . 1 0-2 . 02 
4 .78-1 2 . 1 9  
o .  74-2 . 1 5 
0.61 -1 .72  ---- ----
1 .07-4 .80 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
0 
0 
0 
1 
0 
2 
3 
9 
8 
1 
0 
2 
9 
0 
8 
3 
1 
9 
8 
1 1  
9 
5 
0 
2 
9 
6 
9 
2 
1 1  
. o 
8 
1 0 
Range 
mg/d l  
o .  74-2 . 3 2  
0 .44-6. 2 1 
2 . 07-6 . 57 
0 . 89-2 . 63 
0 . 69-1 . 7 2  
0 . 8 2 -2 . 48 
0 . 2 9- 1 . 35 
0 . 23 -0 . 87 
1 . 4 2-3 . 6 3  
1 . 93 -6 . 08 
0 . 6 1 -2 . 1 9 
1 . 63-9 . 61 
0 . 87-2 . 90 
2 .09-9. 1 1  
0 . 1 6- 1 . 1 5 
0 .93 -2 . 75 
0 
0 
0 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
1 
1 
0 
=4 
5 
1 1  
1 0 
7 
7 
1 0  
1 0 
2 
1 1  
1 0 
0 
1 1  
1 0 
1 0 
9 
4 
>Hax4 
4 
0 
1 
0 
2 
0 
0 
4 
0 
0 
1 1  
0 
1 
o · 
0 
6 
1 Ti kanoja ,  T .  ( 1 982 ) Pl a sma ami no aci ds  i n  term neonates after a feed of human mi l k  or formul a .  Acta Paed i atr . Scand . 7 1 , 
39 1 -397 . 
� 
2
< Mi n = number of i nfants wi th l evel s l ess than mi n imum ; n  breast fed term ; nfants . = i s  number wi th i n range . > Max = 
number exceedi ng max i mum . 
3
Pl asma ami no ac ; ds from umbi l i cal cord sampl es f rom 1 6 premature i nfants ( 27-35 weeks gestati on ) .  Unpubl i shed data from 
thi s l aboratory . 
4< Mi n = number of i nfants with l evel s l ess than mi n imum i n  premature cord pl a sma .  = i s  number wi thi n range . > Max = 
number exceedi ng maxi mum . 
V1 
V1 
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with in the range of concentrations found in umb il i cal plasma. The 
reverse was true for pr�l ine concentration which was w ith in the. range 
observed in breast fed infants in 9 of 1 O cases and wh ich exceeded the 
max imum concentration in the cord plasma of prematures in 6 of 1 0  
infants. Although intake of h isti d ine d id  not exceed recommendations 
in any infant and -was, in fact , below the level recommended for 3 of 
the 1 1  , the plasma concentration tended to be h igher than reference · 
values ( 8  of 9 > breast fed ,  4 of 9 > cord ) .  N ine infants had h igh 
lysine concentrations and 1 O had h igh threonine concentrations when 
compared to values obtained from breast fed infants . · The fact that 
the concentrations of these two amino ac ids q id _ not exceed the range 
observed in umbi l ical cord p lasma . i s  not surprising considering the · 
very h igh cord concentration.  
Two-way analysis  of variance was again used to test for the 
effects of gestational age and amino ac id intake on plasma amino ac id 
concentrat ions • . Postnatal age , found prev iously to be associated w ith 
phenylalanine concentration , was not included because ·all the . infants 
were evaluated on the eighth day of l ife . H istid ine ,  tyrosi_ne , and 
leucine concentrations were associated wi th gestational a·ge , serine 
concentration w ith intake , and prol ine and val ine concentrat ions w ith 
both intake and gestational age (Tables 1 8  & 1 9 ) .  H isti d ine ,  prol ine 
and val ine increased l inearly w ith gestational age • The plot of plasma 
tyrosine concentrati on versus gestational age ,  on the other hand , was 
curvi l inear w ith the point of infl ection at approximately 32 weeks 
Amino ac id  
· H i stid i ne 
Pro l i ne 1 
Va l i ne2 
Tyros ine  
l i nea r 
quadrat ic  
Leuci ne 
l i nea r 
qua d rati c 
TAB LE 1 8  
Linea r reg ress ion of p la sma am i no ac ids  at one week of ag e 
w ith gestationa l ag e 
I ntercept 
-1 . 969 
-5 . 723  
-1 . 898 
61 . 5524 
61 . 5524 
-1 7 . 081 5 
-1 7. 081 5 
S lope 
0. 1 420 
0. 2248 
0. 091 0  
-4. 0709 
0 . 0683 
1 .  1 607 
-0. 0 1 80 
S u m s  of sq ua res 
0. 8067 
3. 271 3 
0 . 5535 
0. 6692 
0. 6852 
0. 0925 
0 . 21 00 
F-va l ue 
8. 03  
1 1 . 84 
. 6. 1 4  
7. 05 
7 . 22 
1 0. 90 
24. 76 
1 Pla sma va l ue a l so va ries w i th pro l i ne inta ke .  
2 Pla sma va lue  a l so va ries w ith va l i ne a n d  ca lori c  inta kes . 
P-va l ue 
0. 0253 
0 . 0 1 08 
0. 0382 
0. 0377 
0. 0362 
0. 0 1 3 1  
0. 00 1 6  
(.11 
...... 
Amino acid  
Serine . 
Prol i ne 1 
Val i ne2 
TAB LE 1 9  
Linear regression of plasma ami no acids at one week of age 
with intake of amino ac id 
Intercept 
1 . 3479 
-5 . 7232 
- 1 . 8983 
S lope 
0 .  01 0 1  
0 . 009 1  
0 . 0092 
· Sums of squares 
0 . 8 248 
2 . 0452 
1 .  9 1 80  
F-va l ue 
6 . 64 
7 . 40 
2 1 . 2 9 
1 Plasma val ue a lso varies with gestational age. 
2 Plasma val ue a lso varies with gestational age and calor ic  intake. 
P-value 
0 . 0299  
0 . 0297 
0 . 00 1 7 
U'1 
0) 
5 9  
( F igu re 1 ) . Plasma leucine concentration increased from 27  to approxi :­
mate ly  32 weeks · gestation , but then appea red to leve l off or  actua l l y  
decrease ( F igu re 2 ) . T h i s  chang e  a fter 32  weeks may b e  specious , 
however , becau se the re was on l y  one . in fant w i th gestationa l age g reat­
er  than 33 weeks .  Over the range of inta kes i n  th i s  study the p lasma 
concentrations of ser ine , va l i ne , and pro l i ne bore l i nea r· re lat ions h i ps 
to the i r  inta kes . 
Re lat ionsh ips between I nta kes , G rowth and 
Plasma Amino Acid Concentration 
W h i le p lasma ami no ac ids  g i ve an immed iate assessment of nu tr i­
t iona l statu s ,  the best i nd icator of adequacy and approp riatene·ss of 
n utrient inta ke is  g rowth . The refore , despite th i s  study 's  l im ited t ime 
frame , an attempt was made to desc r i be certa i n  pa ramete rs of g rowth 
i n  the 1 1  i nfants . 
As ex pected the i n fants lost we ight i n  the fi rst few days a fte r 
b i rth . Max imum weig ht loss va r ied from 7 to 26% of b i rth w�ig ht ·w ith 
a mea n loss of 1 6% ( Tab le  2 0 ) . T h i s  i s . s l ight ly  more tha n the reported · 
nor ma I weig ht loss for prematu res .of 1 0- 1  5% ( 8 3 ) ,  but these i n fants 
tended to be the sma l l er and less matu re i n fants of the or i g i na l  sam­
p l e .  Weig ht ga in  was recorded as ea r ly  as  5 days and as l ate as 1 O 
days w ith a mean postnata l age of  6 .  9 days . At the . .  t ime of fl rst 
weight  g a i n  i n fants were rece iv i ng from 36-82 kca l / kg / day and from 
0 . 2 0-0 . 55 g n i trogen / kg /day ( Ta ble  2 1 ) .  T he re was no corre lation 
between gestationa l age and n it rogen inta ke on the fi rst day of 
g rowth , but the re was a tendency for more immatu re i n fants in  th i s  
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TABLE 20 
Nutrient intake on initial day of weight gain 
tnfant Postnatal day % Lost
1 Calories N itrogen Amino acids 
kcal/ kg/day g / kg/day g / kg/day 
Per 6 26 73 . 55 3 . 45 
Ora 7 1 3  59 . 20 1 . 30 
Dal 5 22 57 . 21 1 . 33 
Lov 6 21 82 . 48 3 . 04 
Yoa 8 17 56 . 22 1 . 38 
Vnc 10 20 57 • 31 1 .  97  
Kop 7. 11 74 . 40 2 . 53 
Sh1 5 14 60 . 35 2 . 18 
Sh2 10 16 69 . 35 2 .  16 °" "' 
Bis 7 1 3  38 . 22 1 .  40 
Cla 5 7 36 . 21 1 .  32 
Means 6 . 9  16 . 4  60 . 1 . 32 2 . 00 
S D  14 .2  . 12 
1 % lost · = max imum % of birth weight lost . 
TAB LE 2 1  
Correlations between gestational age and selected nutrient intakes 
on · initi al day of weight gain 
Subject Age Calories · Nitrogen 
weeks kcal / kg/ day g/ kg/day 
B is 33 38 . 22 
Cla 36 " 36 . 2 1  
Dal 29 57 . 2 1  
Ora 27 59 . 20 
Kop 31 74 . 40 
Lov 29 82 . 4 8  
Per 27 73 . 5 5 
Shl 33 60 . 35 
Sh2 33 . 69 . 35 O"I 
Vnc 31 57 . 3 1 
w 
Yoa 30 56 . 22 
Means 30. 8 60. 1 . 32 
SD 2. 8 1 4. 2  . 1 2  
Range 27-36 36-82 • 20 ... .  55  
Correlat ion coefficient -. 57 -. 32 · · 
Probabil ity · . 06 . 33 
6 4  
sample to begin to grow at lower caloric intakes (correlation coefficient 
= - . 57 ,  p < . 06 ) . · 
Other investigators have reported a · relationsh ip between branched 
chain amino acid concentration and calor ic intake and between branched 
chain amino ac id concentration and growth ( 84) . In th is study con­
centration of vali ne, but not leucine or isoleucine, was significantly 
correlated with caloric intake in the preced ing 24 hours . (Table 22). 
Ne ither individual nor total branched cha in amino acids. were, however, 
associated with growth in the first week of life in these infants 
(Table 23). 
TABLE ·22 
Correlat ions between p lasma branched cha in  ami no acids at one week 
and caloric intake in the precedi ng 24 hours 
Subject Calories · Leuc i ne lsoleuc ine Val i ne 
kcal / kg/24 hours mg / d i  mg /di  mg/di  
Bis 38 -- -- 1. 68 
C la 44 1. 32 0. 82 2. 49 
Ual 73 1. 30 1. 03 2. 90 
Dra 54 1 .. 06 0. 99 1. 46 
Kop 65 1. 48 1. 12 2. 86 
Lov · 61 1. 48 1. 41 2. 53 
Per 77 1. 15 0. 64 2. 83 
Shl 57 1. 48 0. 94 2. 95 
Sh2 54 1. 69 1. 03 2. 73 O') 
Vnc 68 1. 56 0. 96 2. 99 
Yoa 50 1. 60 1. 09 2. 30 
Means 58. 5 1. 41 1. 00 2. 52 
S D  11 .- 9  0. 20 0. 20 0. 51 
Range " 38 -77 1. 06-1. 69 0. 64-1. 41 1. 46-2. 99 
Correlat ion coeff ic ient -. 24 - • 1.7 . 65 
Probabi l ity . 51 . 64 . 03 
TABLE 23 
Correlations ·between plasma branched chain amino acids at one week 
and change in weight in preceding 24 hou·rs 
Subject Weight change Leucine lsoleucine Val ine 
g mg/d i  mg/d i  mg/d i  
Bis 20 -- -- 1 . 68 
Cla -20 1 . 32 0. 82 2. 49 
Dal 0 1 . 30 1 .  03 2. 90 
Dra 20 1 . 06 0. 99 1 . 46 
Kop . 30 1 . 46 1 .  1 2  2. 86 
Lov 30 1 .  48 1 .  41  2. 53 
Per 30 1 .  1 5  0 . 64 2. 83 
Shl - 1 0 1 .  49 0. 94 2 . 95 
Sh2 20 1 . 69 . 1 .  03 2 . 73 
Vnc 0 1 . 56 0. 96 2 . 99 
Yoa 40 1 . 60 1 . 09 2. 30 
Means 1 .  4 1  1 . 00 2. 52 
SD o . 20 0. 20 0. 52 
Correlation coefficient 0 . 09 0 . 36 -0. 26 
Probability . 80 . 31 . 43 
1 Total = leucine + isoleucine + valine. 
Total 
mg/di 
4 . 63 
5. 23 
3 . 51 
5 . 46 
5 . 42 
4. 62 
5. 37 
5. 45 C"I 
5 . 51 
C"I 
4. 99 
5. 02 
0. 63 
-0. 05 
. 90 
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CHAPTER V 
DI SCUSSI ON 
The object ive of this study was to describe the premature infant 's  
plasma amino acid response to  parenteral amino acid  infusi on and to 
determi ne the relat ion of that response to gender , plasma amino acid 
concentrat ion at bi rth , ami no ac id status pr ior to infusion , postnatal 
age , caloric intake , weight , individual amino acid intake , and gesta­
t ional age. The fi rst . part of the study exami ned the init ial response 
(change . in plasma amino acids in the f i rst 24 hours of infusion w ith 
ami no acids) , and the second part evaluated p lasma . ami no acid status 
at one week in infants st i l l  receiving total parenteral nutr it ion with no 
enteral intake. 
Gender was not an influencing factor in the p lasma concentration 
of any am ino ac id before infusion or 24 hours later or in  the change in 
concentrat ion during that interval. This is  in agreement with Berry 
( 85 )  who found no differences in plasma amino acid concentrat ion at 
b irth in infants of dif ferent sexes. 
The amino acid status at bi rth , as reflected by- concentrat ion in  
umbi l ical cord blood , was not associated wi_th plasma amino acid  concen­
trat ion at · the t ime infusions began (age 24-75 hours ).  There was , 
however , no determ inat ion of c i rcadian variat i ons in cord ·values and 
the number. of infants with available cord analyses was small ( n  = 1 O ) .  
Anderson et al. ( 86 ) has reported that plasma amino ac ids levels 
r ise only after a certain minimal intake of amino acids . They found no 
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plasma pool expansion of any amino acid at low levels of intake . In 
the first 24 hours of infusion in this ·study, however, there . was a 
significant increase in concentration of all amino acids contained in the 
infusate except histidine an·d ty_rosine ( Table 5, p .  35) . Increases 
occurred despite very limited intake of amino acids and calories ( mean 
kcal / kg/day = 37 ± 11) .  Low plasma amino· acid levels are thought to · 
reflect deficiency states ( 87 ) ,  suggesting that greater tissue uptake of 
infused amino acids and, therefore, smaller increases in plasma concen­
tration would be found in infants with lower preinfusi on amino _acid 
levels .  This was not supported by the data in this study, however, 
as the percent of change in plasma concentration showed eithe.r no 
association with preinfusion . levels or was greater in · infant_s with low 
preinfusion levels .  It may be that the synthetic capac ity of the most 
deplete.d infants ( those with lowest plasma concentrations ) was ·so limi­
ted that infused amino acids, in excess of those needed for energy, 
. stayed in the plasm.a as part of the infant 's amino acid pool rather 
than being taken up by the tissues for prote in  synthesis . 
Postnatal age, ranging from 24-75 hours at the time infusion 
began, was evaluated as a factor in the infant's  response to pa renteral 
amino acids. · Phenylalanine was the only amino acid signifi<::antly affec-
ted by postnatal age ( Tabl.es 7-9, pp . 38-40 ) . Plasma phenylalanine · 
concentration, absolute change in concentration in the first 24 hours 
of infusion, and the percent of change in concentration all decreased 
as postnatal age increased. This may indicate postnatal maturation of · 
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phenylalanine hydroxylase, the enzyme catalyz , !lg the conversion · of 
phenylalanine to tyrosine (14 ) . Filer (88 ) has reported a decrease in 
the· concentration of threonine with increasing postnatal age, but that 
association was not confirmed in this study. I nfants in the present 
study were tested at 2-4 days as compared to .Filer's  11-35 days, pos­
sibly obscuring a significant slow decline in threonine concentration . 
I t  has been suggested that gluconeogenic mechanisms are post­
natally induced as the infant rapidly depletes his glycogen supply and 
is forced for the first time to supply his own carbohydrate needs (89 ) . 
There was no indication . in this s�udy, however, that postnata l age had 
any bearing on the concentrations of alanine, serine, glycine, cys­
teine, or any other glucogenic amino acid . I nduction of glucogenic 
enzymes may have occurred before amino acid infusion began or may 
have been masked by close monitoring and provision of appropriate 
glucose in both the amino acid solution and the glucose solution given 
since birth . There was also no association between caloric ·intake and 
the plasma concentration of major glucogenic amino acids at the level of · 
caloric intakes in this study . 
Weight, as a reflection of muscle mass, w_as evaluated as a factor 
in plasma concentration of individual amino acids . The amino acids 
most likely to be influenced by muscle mass would be the branched 
chain amino acids because they are metabolized primarily in muscle (29 )  
. and lysine because of its propensity for storage in muscle ( 90 ) . After 
controlling· for gestational age ,  however, weight was not associated 
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w ith the p lasma concentration of any ami no acid after 24  hou rs of 
i n fu s ion or at one week of age . 
The compos itio� and amou nt of  amino ac id s  i n fu sed have been 
found to be re lated to p lasma am ino aci d concentration ( 8 8 , 9 1 -93 ) , but 
the exact re l ation s h i p  i s  not we l l  de fi ned . Anderson et a l . ( 86 )  con­
c luded that " b lood leve ls  do  not bea r a s imp le  d i rect re lat ion s h i p  to 
i nta ke but rather reflect the overa l l  dynamics of the ind iv idua l  b lood 
am ino ac id  pool . "  Changes in am ino ac id concentrat ion a re thoug ht to 
be a ffected by endogenous reg u lation as we l l  as inta ke . The respon se 
of· infa nts in th i s  study to a lan i ne a nd g lycine , added to the infu sate 
as  sou rces of non spec ific  n i trogen , i s  an example of th i s  complex 
i n teraction . 
A lthough recommendation s for sou rces of non spec i fic n itrogen 
have inc l uded g lyc ine , a l an i ne , and the b ranch�d cha i n  am i no acids , 
g lyc ine has been most common ly used , at least pa rtia l ly  beca u se i t  i s  · 
compa rat ive ly  chea p • . The i n fusate used i n  th i s  study conta ined i den­
t ica l amou nts of g lycine and a lan i ne ( 1 28 mg / g  Ami nosy n ) _, but i n fant 
respon se to the two amino acids was d i fferent ( Ta b le 1 2 ,  p • · 46 ) .  Each 
mg of g lyc i ne i n fu sed in the fi rst 24 hou rs resu lted in  an increase i n  
p lasma concentrat ion rough l y  tw ice that o f  a l an ine ( O .  0066 vs . O .  0034 
mg / d i ) . At one week of  age p lasma concentrat ion of g lyci ne in  every 
infant  exceeded the maxi mum observed in b reast fed term i n fa nts - a nd 
i n  preterm mi xed cord b lood.. Maxi mum 'p lasma concentration of  a la n i ne 
i n  study in fants never exceeded · that fou nd in  preterm cord samples 
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a nd was g reate r than the max i mum leve l observed i n  b reast fed te rm 
i n fants in on l y  2 ca ses ( Ta b le 1 7 ,  p. 55 ) .  I n  contrast to g ,l yc i ne , 
a lan i ne d id  not tend to accumu late i.n p lasma at the concentrat ion 
i n fu sed in th i s  study . These observations were made , however ,  at a 
t ime of  ca lor ic defic i t  and  a possi b le  need for en dogenou s g lucose 
syn thesi s .  A lthoug h both a l a n i ne and g lyc i ne a re g lucogen i c ,  g lyc ine 
must fi rst be · converted to se r ine ( 1 4 ) and may not be as read i ly u t i­
l ized as a l an ine . Da le ( 9 4 )  and Poh landt ( 1 0 )  a l so fou nd very h ig h  
tolerance to a lan i ne w ith p lasma concentrat ion increas ing on l y · a t  h igh  
rates of  adm i n i stration . Th i s  experience , a long w i th the know ledg e 
that feta l con�u mption of a la n i ne .i s  the g reatest of any ami no ac id , 
p rompted Poh la.ndt to recommend a max imum dose ot . 700 mg / kg / day of 
a la n i ne , more than  tw ice the max imum recommended for any other amino 
acid . Th i s  study supports the i dea that a l a n i ne , rather than g l yc i ne , 
i s  the better sou rce of nonspeci fic n i trogen in  the prematu re i n fant , at  
l east i n  times of  ca lor ic depr ivat ion . 
Th·e h igh  concentrat ion of g lyc i ne i n  the i n fusate g i ven i n fa nts i n  
th i s  study may have i n fl uenced the respon se o f  se r i ne w hose . p lasma 
concentrat ion at one week wa s d i rect ly assoc iated w i th · i n ta ke 
· ( Ta b le 1 9 , p .  5 8 ) .  Ser i ne and g lyc i ne can be interconverted th roug h 
the g lyc i ne c leavage· 'system ( 95 )  wh ich  i s  · appa rent ly fu nctiona l. in  the 
p reterm i n fant ( 26 ) . I n  th i s  study se r i ne was present i n  re lat ive l y  . 
low concentration i n  the i n fusate ( 42 mg / d I ,  the lowest of any non-
essen tia l  am ino ac id ) . I t  had , however ,  the h ig hest increa se . i n  
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plasma concentration per mg intake in the first 24. hours of infusion 
(Table 11, p. 44 ) .  Other investigators have reported sig11ificant 
increases in plasma serine concentration associated with · .both high 
intakes of serine and glycine (91, 94) and glycine alone (10, · 94 ) .  
The synthesis of serine from glycine requires the addition of ·a one 
carbon fragment which may _be supplied · by methionine, histidine or 
tryptopha� ( 14 ) .  I n  infants in this study one carbon fragment donors · 
are in short supply relative to glycine ( Table 24) .  T_herefore cor:wer­
sion of significant amounts of glycine to serine could result in defi­
ciency of one carbon fragments needed for nucleic acid synthesis and 
thus result in depressed growth and erythropoesis. The failure of 
infants in this study. to fully utilize infused amino acids (as evidenced 
by plasma accumulation ) further compounds the potential problems. 
I n  infants at one week of age plasma prolir:-ie concentration was 
significantly associated with intake (Table 19, p. 58 ) .  Dale (94 ),  
studying postoperative neonates, found a similar linear increase in 
proline concentration with increases in the rate of infusion of a ·syn­
thetic amino acid solution of undescribed composition. Increase in 
plasma proline concentration in infants in this study may have been 
related to the proline concentration of the infusate (86 mg/di ) ,  which 
result�d in intakes greater than the recommended maximu� in 8 of the 
11 infants or the . increase may have been related to . immature renal 
function (96 ) .  The relationship between plasma concentration and 
urinary excretion is supported by the observation of Burger . (97 ) 
that plasma proline concentrations were higher in infants who had 
Acceptor 
Glycine 
Total : 
TABLE 24 
Possible demand and sources of one carbon fragments ffom 100 ml 
intravenous solut ion containing 1 g Aminosyn-
mg 
128 
mmol 
1. 70 
1. 70 
Donors 
Methionine 
Hist id ine 
Tryptophan 
mg 
40 
30 
16 
1 Abbott Laboratories ,  Chi cago, 1 1 1 .  
mmol 
0 . 27 
0 .  19 
0 . 08 
0 . 54 
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relatively little renal loss of proline. Maturation of the · kidney 
resulting in decreased prolinuria might also be related to tbe �ssoci­
ation of increasing plasma proline with advancing gestational age 
( Table 18, p .  57 ) .  
Gestational age as a factor in the premature infant' s  response to 
parenteral · amino acid infusion is of particular interest b�cause of the 
possibility of enzymatic immaturity leading to either amin� acid excess 
( when catabolic pathways are not deveioped ) or to amino acid defici­
ency ( when synthetic pathways are immature ) .  For example, serious 
doubts have been raised about the ab.ility of the pr�term infant to 
synthesize cysteine and taurine from methionine precursors ( 67, 69 ) .  
The absence of both cysteine and taurine from the infusate in this 
study and the presumed inabilit·y to synthesize either suggest that 
their plasma concentrations would fall over time. I n  fact, · however, 
the decline in taurine concentration in the first 24 . hours of infusion 
was insignificant and cysteine had a small but insignificant increase in 
concentration ( Table 5, p. 35) .  Individual infants had as much as a 
_55% increase in taurine and a 114% increase in cysteine values . With 
no intake of either cysteine or taurihe it appears that some infants 
have the enzymatic mechanisms for their synthesis. This ability may 
. . 
not be universal in this population, however, and cannot be predicted 
on the ·basis of gestational age, postnatal age, weight, caloric intake, 
or methionine intake under the · conditions of this study. 
Tyrosine concentration in one week old infants was found to 
increase s ignificantly with gestational age ( Table · 18, p. 57, and 
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Figure 1, p.  60) . This association is presumably due to the increased 
conversion of phenylalanine to tyrosine but the dec line in phenyl­
alanine levels with advancing gestational age did not reach significance 
(p < • 07 ) .  The normal catabolic route for phenylalanine results in the 
synthesis of tyrosine in a reaction catalyzed by phenylalanine 
hydroxylase ( 8 ) . The activity of this enzyme, although present in low 
levels since ea rly in fetal development, normally shows a marked up­
surge in the first day of life ( 7 ) . This description is in . agrE:ement 
with the finding in this study of an association between phenylalanine 
concent ration after 24 hours of infusion and postnatal age ( Tables 7-9, 
pp . 38-40 ) . Although plasma concentrations of phenylalanine and 
tyrosine in some infants exceeded maximum reference values none were 
suggestive of hyperphenylalanemia or tyrosinemia . 
Plasma concentration of histidine in infants one week of age was 
directly related to gestational age ( Table 17, p .  55 ) .  Supplied in the 
infusate in a concent ration of 30 mg /g Aminosyn, histidine intake 
never exceeded the maximum recommended by other investigators, yet 
plasma concentrations tended to be high ( Table 16, p .  53) . Increased 
concent ration in the plasma suggests either increased synthesis, 
decreased utilization, decreased urinary loss or decreased catabolism . 
Of these, decreased catabolism does not seem a likely exp lanation for 
the increase in histidine concent ration . Histidine has 2 major catabolic 
routes ( 7 ) .  The preferred route in most cases begins with conversion 
of histidine to urocanate in a reaction catalyzed by histidase . · In rats . 
this enzyme is detectable at a very low level just before birth but 
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p resumably develops postnatally . In this study histidine concentra- · 
tions after 24 hours of infusion were not associated with postnat�I age . 
The second catabolic reaction involves transamination of histidine by 
histidine-pyruvate !ransaminase , an enzyme developing in the late fetal 
period in rats but apparently not until 6-7 weeks after birth in 
humans ( 7 ) . Although histidine has been considered a nonessential 
amino acid for healthy adults , too l itt le is known about its biosynthesis 
to speculate on the maturation _of synthetic pathways in p rematu re 
infants . Like proline and glycine , histidine is norma lly excreted in 
la rge quantities in the urine of · the premature infant . Decreasing 
rena l loss with advancing gestationa l age may be · the explanation for 
increased plasma histidine concentration , but this relationship could 
not be tested in this study . 
The relationship between plasma leucine concentration and gesta­
tional age is confusing . The gra ph of this relationship (Figure 2 ,  
p .  6 1 ) shows an increase in p lasma . concentration from age · 27 to 
a pproxin:iately 32-33. weeks gestation fol lowed by a decrease in concen­
tration from 33-36 weeks , the upper limit of gestationa l age in the 
sample .  During the study period infants were in a state of energy 
deficit and may have been utilizing bra s:,ched chain amino acids for 
en�rgy . I t  has been proposed that utilization of branched chain amino 
acids is facilitated by ca rnitine ( 9 8 ) , which is found in higher con­
centration in cord b lood of preterm than of term infants ( 99 ) . I f  this 
is true , the utilization of leucine for energy would be facilitated by 
the more p remature infant's  higher carnitine levels .  Decreased 
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u ti l izat ion of leuc ine for energy by the more matu re i n fants wou ld  
resu l t  i n  an increas i ng p lasma concentrat ion of  leuc ine w ith advanc ing 
gestationa l age .  T h i s  i s  the s i tua.t ion depicted between 27  and  33 
wee ks gestation . The fa l l in  p lasma concentration after that t i me must . 
be i n terpreted w ith cau tion becau se of the d i sp roportionate in fluence of 
t he on·e subject of 36  wee ks gestationa l age . 
Va l i ne i s  the on ly  amino ac i d  whose concentra tion at one wee k wa s 
affected by ca lor ic  inta ke ( p < • 0 4 ) . I n  contrast to the othe r 
b ranched cha in  a m i no aci ds wh ich a re pu re ly  ketogen i c  ( leuc ine ) or  
both ketogen ic  and  g l ucogen ic  ( i so leuci ne ) , va l i ne is  pu re ly g l ucogen i c  
( 1 4 ) .  I n fants i n  th i s  study we re in  a state of energy defic i t  ( mea n 
ca lor ic i nta ke < 60 kca l / kg / day at one week ) ,  and  the increa se i n  
p lasma va l i ne concen trat ion assoc iated w i th increased i nta ke may be 
d ue to s i mple va l ine spar ing , 1 i . e . , decreased ut i l i za tion for energy . 
Va l i ne concentrat ion i s  a l so associated w i th. va l i ne inta ke ( Tab le  1 9 ,  
p .  5 8 ) .  I nta ke of va l i ne at one week exceeded the maxi mum recommen-
dation i n  4 o f  1 1  in fants . N i ne ( 9 ) of 1 1  i n fants had p lasma concen-
trations exceed i ng the max i mum observed i n  breast fed babies ,. how-
eve r ,  wh i le  none exceeded the max imum measu red i n  preterm cord 
samples . Li teratu re reports on the re lat ion s h i p  o f  pa rentera l va l i ne 
i nta ke to concentrat ion i n  the p lasma a re s im i l a r . With inta kes u p  to 
200 mg / kg / day , Ghad i mi  ( 1 1 )  found a l l  p lasma va l ues were w i th i n  the 
ra nge of co rd b lood . Poh landt ( 1 0 ) , howeve r ,  found i n fa nts i n fused 
w ith 1 80 mg / kg / day had p lasma concentrations exceed i ng those of 
b reast fed newborn s .  I t  wou ld seem that the ever con fu s i ng question · 
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of appropriate reference values for plasma amino acid levels in. prema­
tures is of particular importance - in the case of valine. Response of 
premature infants to infusions of various amounts of valine should also 
be measured when caloric intake is controlled, a situation not found in 
this study. 
Methionine is another amino acid whose plasma concentration is 
cause for concern. The maximum value reported in breast fed term 
newborns was exceeded in 1 5  of 1 9  infants after 2 4  hours of infusion 
and by all 6 infants whose methionine concentration was measured at 
one week of age. Concentration of methionine in the infusate in this 
study (40 mg/g Aminosyn) appears too high for this population as all 
infan.ts received more methionine per kg/day at one week than recom­
mended. In  laboratory animals methionine was the most toxic amino 
acid, causing inhibition of growth_ and tissue damage when given in 
relatively low excess (100) . Methionine has been shown to be particu­
larly toxic in the young ( 101 ) and when protein intake is inadequate 
(1 02) as it was in this study. The amino acid source (Aminosyn) used 
: in the infusate was not specifically formulated for infants. It is used 
with apparently few problems in adults who are able to synthesize 
cysteine and taurine from methionine · precursors. The premature 
infant may lack this capacity, however, and be able to utilize rela­
tively · smaller amounts of methionine. These limitations are acknowl-
. .  
edged by various investigators making recommendations for methionine 
intake by the premature infant (15-45 mg'/kg/day) ,  but are frequently 
ignored in practice. 
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CHAPTER VI  
SUMMARY 
This study investigated the response of premature infants to 
parenteral amino acids and related that response to various indepen-:­
dent variables. Plasma samples were collected. before the initiation of 
amino acid infusion and after 24 hours of infusion from 21 premature 
infants (gestational age 31. 2 ± 2. 34 weeks) admitted to the Intensive 
Care Nursery of The University of Tennes.see Memorial Research Cen­
ter and Hospital, Knoxville. Mixed umbilical cord blood samples were 
available from 1 O of these infants. Blood samples were · also obtained 
from 11 infants (gestational age 30. 8 ± 2. 8 weeks) receiving parenteral 
amino acids with no ent�ral supplementation at one week . Plasma amino 
acid concentrations were compared to those reported in breast fed term 
infants and in preterm umbilical cord samples. Intakes in the 24 hours 
prior to sampling were calculated and compared to published recommen­
dations. The amino acid source . was Aminosyn (Abbott Laboratories, 
Chicago, I I  I. ) .  
Neither plasma amino acid concentration nor change in concentra­
tion in the first 24 hours of infusion was · affect�d by gender, plasma 
amino acid concentration at birth or weight. Chan�es in concentration 
of most amino acids appeared to be a result of endogenous regulation 
more than simple intake. Alanine infused at a relatively . high concen­
tration (128 or 230 mg/di ) showed relativ�ly little plasma accumulation 
and appeared to be the .best source of nonspecific nitrogen during the 
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hypocaloric cond itions of the .first week of l ife . The sanie concentra­
t ion of glycine in the infusate lead to excessive plasma concen�rations : 
of glycine and may · have contributed to � igh levels of serine. : The 
h igh concentration of glycine in the infusate is not balanced · by ade­
quate sources of one carbon fragments · for serine synthesis. 
Intakes of h isti d ine did not exceed recommendations , but plasma 
h istid ine w�s h igh in most infants . Concentration of plasma h istid ine 
varied d irectly w ith gestational age . 
Plasma phenylalanine levels varied · inversely with postnatal age 
and tyrosine concentrati on varied d irectly with gestational age , sug­
gesting effects of both gestational and postnatal ag·es on the funct ion 
of the phenylal anine hydroxyla se system . In l ight of the very l im ited 
intakes , there was no ev idence of tyrosine being an essential amino 
add in most prematures . 
Although the t ime period was very short , there were ind ications 
of cysteine and taurine synthesis in some infant� . Meth ionine intakes 
exceeded recommendations in al l  infants at one week and were . assoc i­
ated with excessive plasma concentrations . 
Val ine concentration varied d irectly w ith calori c intake , gesta­
tional age , and val ine intake . Leucine concentration increased w ith 
gestational age from 27-32 weeks , but the relat ionsh i p · after that t ime 
i s  unclear. l soleucine concentrat ion . was not affected by any of the 
variables tested . 
Some overal l  concl usions can be reached . First , in these infants 
there is great variabi l i ty in plasma concentration of amino acids and in 
8 1  
the response to infused amino · acids. Preterm infants are not a homo­
genous group. 
Secondly, interpretation of the data is only as good as ·reference 
values used for in�erpretation, and the fact remains that no one ·kn�ws 
the "normal" plasma concentration of amino acids in the preterm infant. · 
The premature infant is a unique · biological entity, at a different 
maturational · 1evel than the term infant anq in a different environment 
than the . fetus of comparable gestational age�  There is no prototype of 
optimal feeding, such as breast milk for the term infant, but evalu­
ation of .amino acid status of prematures fed their own mother's · milk 
might provide a better standard for evaluating other feeaing _ method­
ologies. 
Finally, based on this study and the reference values used, 
Aminosyn does not appear to have the ideal amino acid composition for 
the preterm infant. For use during the first week of life when · intake 
of both amino acids and calories is low, the infusate should contain 
less glycir,e and methionine and possibly less serine, praline, histi­
dine, and valine. Alanine, isoleucine, and possibly leucine could be 
increased in concentration to provide the necessary nitrogen. In 
theory, the optimal practice would be to individually formulate solu­
tions matched to the infant's changing energy intake, maturatio�, and 
metabolic demands. Much research needs to be done, however, before . 
solutions can even be tailored to provide optimal nutrition to the 
preterm parenterally fed infant. 
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